Veralto (NYSE: VLTO) lifts sales 7.6% and buys In-Situ, GlobalVision
Rhea-AI Filing Summary
Veralto Corporation reported stronger results for the three-month period ended July 3, 2026, with sales of $1,474 million, up 7.6% year over year, and net earnings of $241 million, up from $222 million. Gross margin improved to 61.2% driven by pricing, productivity and tariff recoveries. Diluted EPS was $0.98 for the quarter and $2.00 for the first six months on $2,896 million of year‑to‑date sales and $495 million of net earnings.
Water Quality segment sales rose to $908 million in the quarter and $1,782 million year to date, helped by the January acquisition of In‑Situ for $426 million. Product Quality & Innovation delivered $566 million in quarterly sales. Recurring revenue reached $915 million in the quarter and $1,802 million year to date, about 62% of total.
Operating cash flow for the first six months was $522 million. Veralto funded two acquisitions, including GlobalVision for $195 million, issued $725 million of 4.85% senior notes due 2032 and ended with $2,119 million of cash and $3,379 million of debt. The company repurchased $434 million of stock and began a multi‑year 2026 Cost Optimization Program, recording $29 million of restructuring charges toward an expected $85–$105 million total through 2028.
Positive
- None.
Negative
- None.
Filing Explained
As of July 3, 2026, Veralto had 700 million dollars of debt due in September while 317 million dollars remained available under its buyback authorization.
Form 10-Q is the unaudited quarterly report covering interim financial statements and updates to risks and liquidity. The company reports its quarter ended
The company completed a
The share repurchase program authorized up to
Key Figures
Quarter sales: $1,474 million
Quarter net earnings: $241 million
Quarter diluted EPS: $0.98
+5 more
8 metrics
Quarter sales
$1,474 million
Sales for the three-month period ended July 3, 2026
Quarter net earnings
$241 million
Net earnings for the three-month period ended July 3, 2026
Quarter diluted EPS
$0.98
Diluted EPS for the three-month period ended July 3, 2026
Six-month sales
$2,896 million
Sales for the six-month period ended July 3, 2026
Operating cash flow
$522 million
Net cash provided by operating activities for six months ended July 3, 2026
Total debt
$3,379 million
Total debt outstanding as of July 3, 2026
Share repurchases
$434 million
Payments for repurchase of common stock in the first six months of 2026
In-Situ acquisition price
$426 million
Cash consideration for In-Situ, net of cash acquired, in January 2026
Key Terms
core sales, recurring revenue, net investment hedges, cross-currency swap derivative contracts, +2 more
6 terms
core sales financial
"overall revenues increased 7.6% and core sales increased 4.2%"
Core sales are the revenue generated by a company's main, ongoing business activities after removing one-time or unusual items such as proceeds from asset sales, discontinued operations, or temporary boosts. Investors care because core sales show the steady, repeatable demand for a company’s products or services—like judging a store by its regular weekly receipts rather than a single big clearance sale—to better assess growth trends and future earnings potential.
recurring revenue financial
"Recurring revenue includes revenue from consumables, services, spare parts and operating-type leases"
Revenue that a company expects to receive on a regular, predictable basis from ongoing sources such as subscriptions, service contracts, or repeat customer purchases. It matters to investors because it provides steadier cash flow and makes future earnings easier to forecast—like a landlord collecting monthly rent instead of one-off sales—supporting higher valuations and lower risk when those payments are reliable and customers tend to stay.
net investment hedges financial
"designated as a partial hedge of its net investment in foreign operations"
A net investment hedge is a financial step a company takes to protect the reported value of its ownership in foreign subsidiaries from swings in exchange rates. By using derivatives or foreign‑currency borrowings to offset translation gains or losses, the company reduces how much its balance sheet and reported equity jump around when currencies move — like locking a price tag on a foreign store so its value in the home currency stays steadier for investors.
cross-currency swap derivative contracts financial
"entered into cross-currency swap derivative contracts with a total notional amount of $410 million"
restructuring charges financial
"The Company expects to incur total restructuring charges in connection with the 2026 Cost Optimization Program"
Restructuring charges are costs that a company pays when it changes how it operates, like closing factories or laying off employees. These expenses are often one-time and happen to help the company become more efficient in the long run. They matter because they can affect the company's profits and how investors see its future prospects.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
How did Veralto (VLTO) perform in the quarter ended July 3, 2026?
Veralto posted sales of $1,474 million for the three-month period ended July 3, 2026, up 7.6% year over year, with net earnings of $241 million. Gross margin improved to 61.2% and diluted EPS reached $0.98.
What were Veralto (VLTO)'s results for the first six months of 2026?
For the six months ended July 3, 2026, Veralto generated $2,896 million in sales and $495 million in net earnings. Diluted EPS was $2.00, and operating cash flow totaled $522 million, compared with $496 million in the prior-year period.
How much recurring revenue does Veralto (VLTO) generate?
In the quarter ended July 3, 2026, recurring revenue was $915 million of total sales, and for the first six months it was $1,802 million. Management indicated recurring revenue, including consumables, services and leases, represented about 62% of year-to-date sales.
What acquisitions did Veralto (VLTO) complete in 2026?
Veralto acquired In-Situ, Inc. for $426 million in cash, adding environmental water measurement and monitoring solutions to the Water Quality segment. It also bought GlobalVision for approximately CAD $270 million (about $195 million) for the Product Quality & Innovation segment.
What are Veralto (VLTO)'s debt levels and capital return actions?
As of July 3, 2026, Veralto had $3,379 million of total debt and $2,119 million in cash, including new $725 million 4.85% senior notes due 2032. In the first half of 2026 it repurchased $434 million of stock and paid $64 million in dividends.
What is included in Veralto (VLTO)'s 2026 Cost Optimization Program?
The 2026 Cost Optimization Program targets workforce reductions, site consolidations and functional transformation across both segments. Veralto expects $85–$105 million of restructuring charges through 2028 and recorded $29 million of severance-related expense in the first half of 2026, leaving a $22 million liability.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________________________________________________
FORM 10-Q
______________________________________________________________________
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the quarterly period ended July 3, 2026
OR
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||
For the transition period from to
Commission File Number: 001-41770
(Exact name of registrant as specified in its charter)
(State of Incorporation) | (I.R.S. Employer Identification Number) | ||||||||||
(Address of Principal Executive Offices) | (Zip Code) | ||||||||||
Registrant’s telephone number, including area code: 781 -755-3655
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
☒ | Accelerated Filer | ☐ | ||||||||||||||||||
Non-accelerated Filer | ☐ | Smaller Reporting Company | ||||||||||||||||||
Emerging Growth Company | ||||||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒
The number of shares of common stock outstanding at July 21, 2026 was 243,793,344 .
VERALTO CORPORATION
TABLE OF CONTENTS
FORM 10-Q
Page | ||||||||
PART I - | FINANCIAL INFORMATION | |||||||
Item 1. | Financial Statements | |||||||
Consolidated Condensed Balance Sheets | 1 | |||||||
Consolidated Condensed Statements of Earnings | 2 | |||||||
Consolidated Condensed Statements of Comprehensive Income | 3 | |||||||
Consolidated Condensed Statements of Stockholders' Equity | 4 | |||||||
Consolidated Condensed Statements of Cash Flows | 5 | |||||||
Notes to Consolidated Condensed Financial Statements | 6 | |||||||
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 24 | ||||||
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 38 | ||||||
Item 4. | Controls and Procedures | 38 | ||||||
PART II - | OTHER INFORMATION | |||||||
Item 1. | Legal Proceedings | 39 | ||||||
Item 1A. | Risk Factors | 39 | ||||||
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 39 | ||||||
Item 5. | Other Information | 39 | ||||||
Item 6. | Exhibits | 40 | ||||||
Signatures | 41 | |||||||
Table of Contents
VERALTO CORPORATION
CONSOLIDATED CONDENSED BALANCE SHEETS
($ in millions, except per share amounts)
(unaudited)
July 3, 2026 | December 31, 2025 | ||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Trade accounts receivable, less allowance for credit losses of $ | |||||||||||
Inventories: | |||||||||||
Finished goods | |||||||||||
Work in process | |||||||||||
Raw materials | |||||||||||
Total inventories | |||||||||||
Prepaid expenses and other current assets | |||||||||||
Total current assets | |||||||||||
Property, plant and equipment, net of accumulated depreciation of $ | |||||||||||
Other long-term assets | |||||||||||
Goodwill | |||||||||||
Other intangible assets, net | |||||||||||
Total assets | $ | $ | |||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||
Current liabilities: | |||||||||||
Current portion of long-term debt | $ | $ | |||||||||
Trade accounts payable | |||||||||||
Accrued expenses and other liabilities | |||||||||||
Total current liabilities | |||||||||||
Other long-term liabilities | |||||||||||
Long-term debt | |||||||||||
Stockholders' Equity: | |||||||||||
Preferred stock - $ | |||||||||||
Common stock - $ | |||||||||||
Additional paid-in capital | |||||||||||
Treasury stock | ( | ||||||||||
Retained earnings | |||||||||||
Accumulated other comprehensive loss | ( | ( | |||||||||
Total Veralto stockholders' equity | |||||||||||
Noncontrolling interests | |||||||||||
Total stockholders' equity | |||||||||||
Total liabilities and stockholders' equity | $ | $ | |||||||||
See the accompanying Notes to the Consolidated Condensed Financial Statements.
1
Table of Contents
VERALTO CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS
($ and shares in millions, except per share amounts)
(unaudited)
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | ||||||||||||||||||||
Sales | $ | $ | $ | $ | |||||||||||||||||||
Cost of sales | ( | ( | ( | ( | |||||||||||||||||||
Gross profit | |||||||||||||||||||||||
Operating costs: | |||||||||||||||||||||||
Selling, general and administrative expenses | ( | ( | ( | ( | |||||||||||||||||||
Research and development expenses | ( | ( | ( | ( | |||||||||||||||||||
Operating profit | |||||||||||||||||||||||
Nonoperating income (expense): | |||||||||||||||||||||||
Other income (expense), net | ( | ||||||||||||||||||||||
Interest expense, net | ( | ( | ( | ( | |||||||||||||||||||
Earnings before income taxes | |||||||||||||||||||||||
Income taxes | ( | ( | ( | ( | |||||||||||||||||||
Net earnings | $ | $ | $ | $ | |||||||||||||||||||
Net earnings per common share: | |||||||||||||||||||||||
Basic | $ | $ | $ | $ | |||||||||||||||||||
Diluted | $ | $ | $ | $ | |||||||||||||||||||
Average common stock and common equivalent shares outstanding: | |||||||||||||||||||||||
Basic | |||||||||||||||||||||||
Diluted | |||||||||||||||||||||||
See the accompanying Notes to the Consolidated Condensed Financial Statements.
2
Table of Contents
VERALTO CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
($ in millions)
(unaudited)
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | ||||||||||||||||||||
Net earnings | $ | $ | $ | $ | |||||||||||||||||||
Other comprehensive income (loss), net of income taxes: | |||||||||||||||||||||||
Foreign currency translation adjustments | ( | ( | |||||||||||||||||||||
Pension and post-retirement plan benefit adjustments | ( | ||||||||||||||||||||||
Unrealized gain (loss) on net investment hedges | ( | ( | |||||||||||||||||||||
Total other comprehensive income (loss), net of income taxes | ( | ( | |||||||||||||||||||||
Comprehensive income | $ | $ | $ | $ | |||||||||||||||||||
See the accompanying Notes to the Consolidated Condensed Financial Statements.
3
Table of Contents
VERALTO CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY
($ and shares in millions)
(unaudited)
Common Stock | |||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Additional Paid-In Capital | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interests | |||||||||||||||||||||||||||||||||||
Balance, December 31, 2025 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||
Net earnings for the period | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Dividends declared | — | — | — | — | ( | — | — | ||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — | — | ( | — | ||||||||||||||||||||||||||||||||||
Repurchase of common stock | ( | — | — | ( | — | — | — | ||||||||||||||||||||||||||||||||||
Common stock-based award activity | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Balance, April 3, 2026 | $ | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||
Net earnings for the period | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Dividends declared | — | — | — | — | ( | — | — | ||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — | — | ( | — | ||||||||||||||||||||||||||||||||||
Repurchase of common stock | ( | — | — | ( | — | — | — | ||||||||||||||||||||||||||||||||||
Common stock-based award activity | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Change in noncontrolling interests | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Balance, July 3, 2026 | $ | $ | $ | ( | $ | $ | ( | $ | |||||||||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||||||||||||||
Shares | Amount | Additional Paid-In Capital | Treasury Stock | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Noncontrolling Interests | |||||||||||||||||||||||||||||||||||
Balance, December 31, 2024 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||
Net earnings for the period | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Dividends declared | — | — | — | — | ( | — | — | ||||||||||||||||||||||||||||||||||
Separation related adjustments | — | — | ( | — | — | — | — | ||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Common stock-based award activity | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Balance, April 4, 2025 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||
Net earnings for the period | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Dividends declared | — | — | — | — | ( | — | — | ||||||||||||||||||||||||||||||||||
Other comprehensive income (loss) | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Common stock-based award activity | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Change in noncontrolling interests | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Balance, July 4, 2025 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||
See the accompanying Notes to the Consolidated Condensed Financial Statements.
4
Table of Contents
VERALTO CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
($ in millions)
(unaudited)
Six-Month Period Ended | |||||||||||
July 3, 2026 | July 4, 2025 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net earnings | $ | $ | |||||||||
Noncash items: | |||||||||||
Depreciation | |||||||||||
Amortization of intangible assets | |||||||||||
Stock-based compensation expense | |||||||||||
Loss on product line dispositions | |||||||||||
Gain from the step acquisition of previously held minority interest | ( | ||||||||||
Change in trade accounts receivable, net | ( | ( | |||||||||
Change in inventories | ( | ( | |||||||||
Change in trade accounts payable | |||||||||||
Change in prepaid expenses and other assets | ( | ( | |||||||||
Change in accrued expenses and other liabilities | |||||||||||
Net cash provided by operating activities | |||||||||||
Cash flows from investing activities: | |||||||||||
Cash paid for acquisitions, net of cash acquired | ( | ||||||||||
Payments for additions to property, plant and equipment | ( | ( | |||||||||
All other investing activities | ( | ( | |||||||||
Net cash used in investing activities | ( | ( | |||||||||
Cash flows from financing activities: | |||||||||||
Payment of dividends | ( | ( | |||||||||
Proceeds from the issuance of common stock in connection with stock-based compensation | |||||||||||
Payments for repurchase of common stock | ( | ||||||||||
Net proceeds from borrowings (maturities longer than 90 days) | |||||||||||
Net cash provided by (used in) financing activities | ( | ||||||||||
Effect of exchange rate changes on cash and cash equivalents | ( | ||||||||||
Net change in cash and cash equivalents | |||||||||||
Beginning balance of cash and cash equivalents | |||||||||||
Ending balance of cash and cash equivalents | $ | $ | |||||||||
Supplemental disclosures: | |||||||||||
Cash interest payments | $ | $ | |||||||||
Cash income tax payments | $ | $ | |||||||||
See the accompanying Notes to the Consolidated Condensed Financial Statements.
5
Table of Contents
VERALTO CORPORATION
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(unaudited)
NOTE 1. GENERAL
Veralto Corporation’s (“Veralto” or the “Company”) unifying purpose is Safeguarding the World’s Most Vital ResourcesTM. Its diverse group of leading operating companies provides essential technology solutions that monitor, enhance and protect key resources around the globe. The Company is committed to the advancement of public health and safety and believes it is positioned to support its customers as they address large global challenges including environmental resource sustainability, water scarcity, management of severe weather events, food and pharmaceutical security, and the impact of an aging workforce. Through its core offerings in water analytics, water treatment, marking and coding and packaging and color, customers look to the Company’s solutions to help ensure the safety, quality, efficiency and reliability of their products, processes and people globally. The Company operates through two
Basis of Presentation—Veralto prepared the unaudited Consolidated Condensed Financial Statements included herein in accordance with accounting principles generally accepted in the United States (“GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) applicable for interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations; however, the Company believes the disclosures are adequate to make the information presented not misleading. The Consolidated Condensed Financial Statements included herein should be read in conjunction with the audited annual Consolidated Financial Statements as of and for the year ended December 31, 2025 and the Notes thereto included within the 2025 Annual Report on Form 10-K.
There have been no changes to the Company’s significant accounting policies described within the 2025 Annual Report on Form 10-K that have a material impact on the Company’s Consolidated Condensed Financial Statements and the related Notes.
Cash and Cash Equivalents—The Company considers all highly liquid investments with a maturity of three months or less at the date of purchase to be cash equivalents.
Operating Leases—As of July 3, 2026 and December 31, 2025, operating lease right-of-use assets where the Company was the lessee were $194 million and $195 million, respectively, and are included within other long-term assets in the accompanying Consolidated Condensed Balance Sheets. The associated operating lease liabilities were $204 million and $206 million as of July 3, 2026 and December 31, 2025, respectively, and are included in accrued expenses and other liabilities and other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets.
Prepaid Expenses and Other Current Assets—Prepaid expenses and other current assets primarily result from advance payments to vendors for goods and services and are capitalized until the related goods are received or
6
Table of Contents
NOTE 2. ACQUISITIONS
The Company continually evaluates potential acquisitions that either strategically fit with the Company’s existing portfolio or expand the Company’s portfolio into a new and attractive business area. The Company has completed a number of acquisitions that have been accounted for as purchases and have resulted in the recognition of goodwill in the Company’s financial statements. This goodwill arises because the purchase prices for these businesses exceed the fair value of acquired identifiable net assets due to the purchase prices reflecting a number of factors including the future earnings and cash flow potential of these businesses, the multiple to earnings, cash flow and other factors at which similar businesses have been purchased by other acquirers, the competitive nature of the processes by which the Company acquired the businesses, the avoidance of the time and costs which would be required (and the associated risks that would be encountered) to enhance the Company’s existing product offerings to key target markets and enter into new and profitable businesses and the complementary strategic fit and resulting synergies these businesses bring to existing operations.
The Company makes an initial allocation of the purchase price at the date of acquisition based upon its understanding of the fair value of the acquired assets and assumed liabilities. The Company obtains the information used for the purchase price allocation during due diligence and through other sources. In the months after closing, as the Company obtains additional information about the acquired assets and liabilities, including through tangible and intangible asset appraisals, and learns more about the newly acquired business, it is able to refine the estimates of fair value and more accurately allocate the purchase price. The fair values of acquired intangibles are determined based on estimates and assumptions that are deemed reasonable by the Company. Significant assumptions include the discount rates and certain assumptions that form the basis of the forecasted results of the acquired business including earnings before interest, taxes, depreciation and amortization (“EBITDA”), revenue, revenue growth rates, royalty rates and technology obsolescence rates. These assumptions are forward looking and could be affected by future economic and market conditions. The Company engages third-party valuation specialists who review the Company’s critical assumptions and calculations of the fair value of acquired intangible assets in connection with significant acquisitions. Only facts and circumstances that existed as of the acquisition date are considered for subsequent adjustment. The Company will make appropriate adjustments to the purchase price allocation prior to completion of the one-year measurement period, as required.
The following briefly describes the Company’s acquisition activity for the three and six-month periods ended July 3, 2026.
On January 22, 2026, the Company completed the acquisition of 100 % of the outstanding shares of In-Situ, Inc. (“In-Situ”), a global leader in environmental water measurement and monitoring solutions with a leading portfolio of water quality sondes, water quality sensors and data management solutions that help customers monitor and measure the quality or quantity of surface and groundwater. The total purchase price was cash consideration of approximately $426 million, net of cash acquired. In-Situ is included in the Water Quality segment. The Company completed the In-Situ acquisition using cash on hand. The Company preliminarily recorded approximately $223 million of goodwill related to the In-Situ acquisition. The full amount of goodwill is non-deductible for tax purposes.
Prior to the acquisition, the Company held a minority ownership interest in In-Situ that was accounted for using a measurement alternative that measures the securities at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. The acquisition was accounted for as a step acquisition, which required remeasurement of the Company’s
7
Table of Contents
pre-existing equity interest in In-Situ immediately prior to the completion of the acquisition to its estimated fair value. The remeasurement resulted in a pre-tax gain of approximately $7 million, which was recorded in other income (expense), net in the Consolidated Condensed Statements of Earnings.
The following summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for the individually significant acquisition of In-Situ during the six-month period ended July 3, 2026:
($ in millions) | In-Situ | ||||
Trade accounts receivable | $ | ||||
Inventories | |||||
Property, plant and equipment | |||||
Intangible assets - trade names | |||||
Intangible assets - developed technology | |||||
Intangible assets - customer relationships | |||||
Goodwill | |||||
Deferred tax liabilities | ( | ||||
Other assets and liabilities, net | ( | ||||
Net assets acquired | $ | ||||
Less: noncash gain on previously held minority interest | ( | ||||
Net cash consideration | $ | ||||
On April 7, 2026, the Company completed the acquisition of 100 % of the outstanding shares of GlobalVision for approximately CAD $270 million ($195 million), net of cash acquired. GlobalVision leverages its core proprietary deterministic technology with AI-augmented functionality to help pharmaceutical and consumer-packaged goods customers accelerate their speed to market and meet critical quality and packaging compliance regulations, verifying that packaging content remains accurate and compliant at every critical hand-off. GlobalVision will be integrated into the Product Quality & Innovation segment. The Company completed the GlobalVision acquisition using cash on hand. The Company preliminarily recorded approximately $134 million of goodwill related to the GlobalVision acquisition. The full amount of goodwill is expected to be non-deductible for tax purposes.
The weighted-average amortization periods for definite-lived intangible assets acquired during the six-month period ended July 3, 2026 are 11 years for customer relationships, 10 years for developed technology, and 15 years for trade names. The weighted-average amortization period for definite-lived intangible assets acquired in aggregate during the six-month period ended July 3, 2026 is 11 years.
Transaction-related costs for the In-Situ and GlobalVision acquisitions were $3 million and $8 million for the three and six-month periods ended July 3, 2026, respectively.
Pro Forma Financial Information
Pro forma financial information for the In-Situ and GlobalVision acquisitions has not been presented because the acquisitions were not material to the Company’s Consolidated Condensed Statements of Earnings.
8
Table of Contents
NOTE 3. NET EARNINGS PER COMMON SHARE
Basic net earnings per common share (“EPS”) is calculated by dividing net earnings by the weighted average number of shares of common stock outstanding for the applicable period. Diluted EPS is computed based on the weighted average number of shares of common stock outstanding increased by the number of additional shares that would have been outstanding had the potentially dilutive shares of common stock been issued and reduced by the number of shares the Company could have repurchased with the proceeds from the issuance of the potentially dilutive shares.
Information related to the calculation of net earnings per common share for the three and six-month periods ended July 3, 2026 and July 4, 2025 is summarized as follows:
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
($ and shares in millions, except per share amounts) | July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | |||||||||||||||||||
Numerator: | |||||||||||||||||||||||
Net earnings | $ | $ | $ | $ | |||||||||||||||||||
Denominator: | |||||||||||||||||||||||
Weighted average common shares outstanding used in Basic EPS | |||||||||||||||||||||||
Incremental shares from assumed exercise of dilutive options and vesting of dilutive restricted stock units ("RSUs") and performance stock units ("PSUs") | |||||||||||||||||||||||
Weighted average common shares outstanding used in Diluted EPS | |||||||||||||||||||||||
Basic EPS | $ | $ | $ | $ | |||||||||||||||||||
Diluted EPS | $ | $ | $ | $ | |||||||||||||||||||
9
Table of Contents
NOTE 4. REVENUE
The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and six-month periods ended July 3, 2026 and July 4, 2025. Sales taxes and other usage-based taxes collected from customers are excluded from revenue.
($ in millions) | Water Quality | Product Quality & Innovation | Total | ||||||||||||||
For the Three-Month Period Ended July 3, 2026: | |||||||||||||||||
Geographical region: | |||||||||||||||||
North America(a) | $ | $ | $ | ||||||||||||||
Western Europe | |||||||||||||||||
Other developed markets | |||||||||||||||||
High-growth markets(b) | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
Revenue type: | |||||||||||||||||
Recurring | $ | $ | $ | ||||||||||||||
Nonrecurring | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
For the Three-Month Period Ended July 4, 2025: | |||||||||||||||||
Geographical region: | |||||||||||||||||
North America(a) | $ | $ | $ | ||||||||||||||
Western Europe | |||||||||||||||||
Other developed markets | |||||||||||||||||
High-growth markets(b) | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
Revenue type: | |||||||||||||||||
Recurring | $ | $ | $ | ||||||||||||||
Nonrecurring | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
10
Table of Contents
($ in millions) | Water Quality | Product Quality & Innovation | Total | ||||||||||||||
For the Six-Month Period Ended July 3, 2026: | |||||||||||||||||
Geographical region: | |||||||||||||||||
North America(a) | $ | $ | $ | ||||||||||||||
Western Europe | |||||||||||||||||
Other developed markets | |||||||||||||||||
High-growth markets(b) | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
Revenue type: | |||||||||||||||||
Recurring | $ | $ | $ | ||||||||||||||
Nonrecurring | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
For the Six-Month Period Ended July 4, 2025: | |||||||||||||||||
Geographical region: | |||||||||||||||||
North America(a) | $ | $ | $ | ||||||||||||||
Western Europe | |||||||||||||||||
Other developed markets | |||||||||||||||||
High-growth markets(b) | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
Revenue type: | |||||||||||||||||
Recurring | $ | $ | $ | ||||||||||||||
Nonrecurring | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
(a) The Company defines North America as the United States and Canada.
(b) The Company defines high-growth markets as developing markets of the world which include Asia (with the exception of Japan, Australia and New Zealand), Latin America (including Mexico), the Middle East, Eastern Europe and Africa. The Company defines developed markets as all markets of the world that are not high-growth markets.
The Company sells equipment to customers as well as consumables and services, some of which customers purchase on a recurring basis. Consumables sold for use with the equipment sold by the Company are typically critical to the use of the equipment and are typically used on a one-time or limited basis, requiring frequent replacement in the customer’s operating cycle. Examples of these consumables include chemistries for water testing instruments and cartridges for marking and coding equipment. Additionally, some of the Company’s consumables are used on a stand-alone basis, such as water treatment solutions. The Company separates its goods and services between those typically sold to a customer on a recurring basis and those typically sold to a customer on a nonrecurring basis. Recurring revenue includes revenue from consumables, services, spare parts and operating-type leases (“OTLs”). Nonrecurring revenue includes sales of equipment and sales-type leases (“STLs”). OTLs and STLs are included in the above revenue amounts. For the three-month periods ended July 3, 2026 and July 4, 2025, lease revenue was $26 million and $21 million, respectively. For the six-month periods ended July 3, 2026 and July 4, 2025, lease revenue was $46 million and $43 million, respectively. Service and software revenue was immaterial for all periods presented. Software revenues for point-in-time licenses are nonrecurring while revenues for Software as a Service and over time licenses are recurring.
Remaining performance obligations related to Topic 606, Revenue from Contracts with Customers, represent the aggregate transaction price allocated to performance obligations with an original contract term greater than one year which are fully or partially unsatisfied at the end of the period. As of July 3, 2026, the aggregate amount of the transaction price allocated to remaining performance obligations was $354 million. The Company expects to recognize revenue on approximately 40 % of the remaining performance obligations over the next 12 months, 38 % over the subsequent 12 months, and the remainder recognized thereafter.
11
Table of Contents
NOTE 5. SEGMENT INFORMATION
The Company operates and reports its results in two
The Company’s Water Quality segment provides proprietary precision instrumentation, consumables, software, services and advanced water treatment technologies to help measure, analyze and treat the world’s water in municipal, industrial, commercial, residential, research and natural resource applications.
The Company’s Product Quality & Innovation segment provides equipment, consumables, software and services for various marking and coding, traceability, printing, packaging design and quality management, packaging converting and color and appearance management applications for consumer-packaged goods and industrial products.
Resources are allocated and performance is assessed by the President & Chief Executive Officer (CEO), whom the Company has determined to be the Chief Operating Decision Maker (“CODM”). The CODM evaluates the performance of its segments and allocates resources to them based on operating profit. The CODM also compares actual results to expectations in assessing performance of the segments. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance.
The identifiable assets by segment are those used in each segment’s operations. Intersegment amounts are not significant and are eliminated to arrive at combined totals.
12
Table of Contents
Detailed segment data for the three and six-month periods ended July 3, 2026 and July 4, 2025 is as follows:
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
($ in millions) | July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | |||||||||||||||||||
Sales: | |||||||||||||||||||||||
Water Quality | $ | $ | $ | $ | |||||||||||||||||||
Product Quality & Innovation | |||||||||||||||||||||||
Total | $ | $ | $ | $ | |||||||||||||||||||
Operating profit: | |||||||||||||||||||||||
Water Quality | $ | $ | $ | $ | |||||||||||||||||||
Product Quality & Innovation | |||||||||||||||||||||||
Other | ( | ( | ( | ( | |||||||||||||||||||
Total | $ | $ | $ | $ | |||||||||||||||||||
Depreciation and amortization of intangible assets: | |||||||||||||||||||||||
Water Quality | $ | $ | $ | $ | |||||||||||||||||||
Product Quality & Innovation | |||||||||||||||||||||||
Total | $ | $ | $ | $ | |||||||||||||||||||
Capital expenditures: | |||||||||||||||||||||||
Water Quality | $ | $ | $ | $ | |||||||||||||||||||
Product Quality & Innovation | |||||||||||||||||||||||
Total | $ | $ | $ | $ | |||||||||||||||||||
Identifiable assets by segment as of July 3, 2026 and December 31, 2025 are as follows:
($ in millions) | July 3, 2026 | December 31, 2025 | |||||||||
Water Quality | $ | $ | |||||||||
Product Quality & Innovation | |||||||||||
Other | |||||||||||
Total | $ | $ | |||||||||
13
Table of Contents
Reconciliations of total segment sales to total segment operating profit and of total segment operating profit to total consolidated earnings before income taxes, for the three and six-month periods ended July 3, 2026 and July 4, 2025 are as follows:
Three-Month Period Ended July 3, 2026 | ||||||||||||||||||||||||||
($ in millions) | Water Quality | Product Quality & Innovation | Other | Total | ||||||||||||||||||||||
Sales | $ | $ | $ | $ | ||||||||||||||||||||||
Less: other segment items | ( | ( | ( | ( | ||||||||||||||||||||||
Segment operating profit | $ | $ | $ | ( | $ | |||||||||||||||||||||
Other income (expense), net | ||||||||||||||||||||||||||
Interest expense, net | ( | |||||||||||||||||||||||||
Earnings before income taxes | $ | |||||||||||||||||||||||||
Three-Month Period Ended July 4, 2025 | ||||||||||||||||||||||||||
($ in millions) | Water Quality | Product Quality & Innovation | Other | Total | ||||||||||||||||||||||
Sales | $ | $ | $ | $ | ||||||||||||||||||||||
Less: other segment items | ( | ( | ( | ( | ||||||||||||||||||||||
Segment operating profit | $ | $ | $ | ( | $ | |||||||||||||||||||||
Other income (expense), net | ||||||||||||||||||||||||||
Interest expense, net | ( | |||||||||||||||||||||||||
Earnings before income taxes | $ | |||||||||||||||||||||||||
Six-Month Period Ended July 3, 2026 | ||||||||||||||||||||||||||
($ in millions) | Water Quality | Product Quality & Innovation | Other | Total | ||||||||||||||||||||||
Sales | $ | $ | $ | $ | ||||||||||||||||||||||
Less: other segment items | ( | ( | ( | ( | ||||||||||||||||||||||
Segment operating profit | $ | $ | $ | ( | $ | |||||||||||||||||||||
Other income (expense), net | ||||||||||||||||||||||||||
Interest expense, net | ( | |||||||||||||||||||||||||
Earnings before income taxes | $ | |||||||||||||||||||||||||
Six-Month Period Ended July 4, 2025 | ||||||||||||||||||||||||||
($ in millions) | Water Quality | Product Quality & Innovation | Other | Total | ||||||||||||||||||||||
Sales | $ | $ | $ | $ | ||||||||||||||||||||||
Less: other segment items | ( | ( | ( | ( | ||||||||||||||||||||||
Segment operating profit | $ | $ | $ | ( | $ | |||||||||||||||||||||
Other income (expense), net | ( | |||||||||||||||||||||||||
Interest expense, net | ( | |||||||||||||||||||||||||
Earnings before income taxes | $ | |||||||||||||||||||||||||
14
Table of Contents
NOTE 6. INCOME TAXES
The following table summarizes the Company’s effective tax rate:
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | ||||||||||||||||||||
Effective tax rate | % | % | % | % | |||||||||||||||||||
The Company operates globally, including in certain jurisdictions with higher statutory tax rates than the United States (“U.S.”). Therefore, based on earnings mix, the impact of operating in such jurisdictions may contribute to a higher effective tax rate compared to the U.S. federal statutory tax rate.
The effective tax rate for the three-month period ended July 3, 2026 differs from the U.S. federal statutory rate of 21 % principally due to the geographic mix of earnings described above, the favorable impact of tax law changes under the One Big Beautiful Bill Act (“OBBBA”), a net discrete benefit of $12 million related primarily to the impact of restructuring costs and amended return filings. The net discrete benefit decreased the effective tax rate by 2.9 % for the three-month period ended July 3, 2026.
The effective tax rate for the six-month period ended July 3, 2026 differs from the U.S. federal statutory rate of 21 % principally due to the geographic mix of earnings described above, the favorable impact of tax law changes under the One Big Beautiful Bill Act (“OBBBA”), a net discrete benefit of $10 million related primarily to the impact of restructuring costs and amended return filings. The net discrete benefit decreased the effective tax rate by 0.6 % for the six-month period ended July 3, 2026.
The effective tax rate for the three-month period ended July 4, 2025 differs from the U.S. federal statutory rate of 21 % principally due to the geographic mix of earnings described above.
The effective tax rate for the six-month period ended July 4, 2025 differs from the U.S. federal statutory rate of 21 % principally due to the geographic mix of earnings described above, the unfavorable impact of a non-deductible loss on the sale of a product line of $2 million, and a net discrete benefit of $2 million related primarily to the impact of excess tax benefits from stock-based compensation, partially offset by the impact of uncertain tax positions. The net discrete benefit decreased the effective tax rate by 0.3 % for the six-month period ended July 4, 2025.
For a description of the Company’s significant tax matters, reference is made to the financial statements as of and for the year ended December 31, 2025 and Note 6 to the financial statements included within the 2025 Annual Report on Form 10-K.
NOTE 7. GOODWILL AND OTHER INTANGIBLE ASSETS
The following is a rollforward of the Company’s goodwill:
($ in millions) | |||||
Balance, December 31, 2025 | $ | ||||
Attributable to 2026 acquisitions | |||||
Foreign currency translation and other | ( | ||||
Balance, July 3, 2026 | $ | ||||
The carrying value of goodwill by segment is summarized as follows:
($ in millions) | July 3, 2026 | December 31, 2025 | |||||||||
Water Quality | $ | $ | |||||||||
Product Quality & Innovation | |||||||||||
Total | $ | $ | |||||||||
The Company has not identified any goodwill impairment indicators in the three and six-month periods ended July 3, 2026.
15
Table of Contents
NOTE 8. FAIR VALUE MEASUREMENTS
Accounting standards define fair value based on an exit price model, establish a framework for measuring fair value for assets and liabilities required to be carried at fair value and provide for certain disclosures related to the valuation methods used within the valuation hierarchy as established within the accounting standards. This hierarchy prioritizes the inputs into three broad levels as follows.
•Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.
•Level 2 inputs are quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets in markets that are not active, or other observable characteristics for the asset or liability, including interest rates, yield curves and credit risks, or inputs that are derived principally from, or corroborated by, observable market data through correlation.
•Level 3 inputs are unobservable inputs based on the Company’s assumptions. A financial asset’s or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
A summary of financial assets and liabilities that are measured at fair value on a recurring basis were as follows:
($ in millions) | Quoted Prices in Active Market (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | |||||||||||||||||||
July 3, 2026 | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Cross-currency swap derivative contracts | $ | $ | $ | $ | |||||||||||||||||||
Total Assets | $ | $ | $ | $ | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||
Deferred compensation liabilities | $ | $ | $ | $ | |||||||||||||||||||
Cross-currency swap derivative contracts | |||||||||||||||||||||||
Total Liabilities | $ | $ | $ | $ | |||||||||||||||||||
December 31, 2025 | |||||||||||||||||||||||
Liabilities: | |||||||||||||||||||||||
Deferred compensation liabilities | $ | $ | $ | $ | |||||||||||||||||||
Cross-currency swap derivative contracts | |||||||||||||||||||||||
Total Liabilities | $ | $ | $ | $ | |||||||||||||||||||
Certain management employees participate in the Company’s nonqualified deferred compensation programs, which permit such employees to defer a portion of their compensation, on a pretax basis, until after their termination of employment. All amounts deferred under such plans are unfunded, unsecured obligations and are presented as a component of the compensation and benefits accrual included in other long-term liabilities in the accompanying Consolidated Condensed Balance Sheets. Participants may choose among alternative earnings rates for the amounts they defer, which are primarily based on investment options within the defined contribution plans for the benefit of U.S. employees (“401(k) Programs”) (except that the earnings rates for amounts contributed unilaterally by the Company are entirely based on changes in the value of the Company’s common stock). Changes in the deferred compensation liability under these programs are recognized based on changes in the fair value of the participants’ accounts, which are based on the applicable earnings rates.
The cross-currency swap derivative contracts are classified as Level 2 in the fair value hierarchy as they are measured using the income approach with the relevant interest rates and current currency exchange rates and forward curves as inputs. Refer to Note 10 for additional information.
16
Table of Contents
Fair Value of Financial Instruments
The carrying amounts and fair values of the Company’s financial instruments were as follows:
July 3, 2026 | December 31, 2025 | ||||||||||||||||||||||
($ in millions) | Carrying Amount | Fair Value | Carrying Amount | Fair Value | |||||||||||||||||||
Debt Obligations: | |||||||||||||||||||||||
Current portion of long-term debt | $ | $ | $ | $ | |||||||||||||||||||
Long-term debt | |||||||||||||||||||||||
As of July 3, 2026 and December 31, 2025, short and long-term borrowings were categorized as Level 1. The fair value of long-term borrowings was based on quoted market prices. The difference between the fair value and the carrying amounts of long-term borrowings is attributable to changes in market interest rates and/or the Company’s credit ratings subsequent to the incurrence of the borrowing. The fair values of borrowings with original maturities of one year or less, as well as cash and cash equivalents, trade accounts receivable, net and trade accounts payable, generally approximate their carrying amounts due to the short-term maturities of these instruments.
NOTE 9. FINANCING
As of July 3, 2026, the Company was in compliance with all of its debt covenants. The components of the Company’s debt were as follows:
($ in millions) | Outstanding Amount | |||||||||||||
Description and Aggregate Principal Amount | July 3, 2026 | December 31, 2025 | ||||||||||||
$ | $ | |||||||||||||
Total debt | ||||||||||||||
Less: current portion of long-term debt | ( | ( | ||||||||||||
Long-term debt | $ | $ | ||||||||||||
Unamortized debt discounts and debt issuance costs totaled $18 million and $14 million as of July 3, 2026 and December 31, 2025, respectively. Debt discounts and issuance costs are presented as a reduction of debt in the Consolidated Condensed Balance Sheets and are amortized as a component of interest expense over the term of the related debt. Refer to Note 12 of the 2025 Annual Report on Form 10-K for a description of the Company’s debt financing.
There were no
Senior Unsecured Notes
On June 1, 2026, the Company completed an underwritten offering of $725 million aggregate principal amount of senior unsecured notes with a maturity date on January 15, 2032 (the “2032 Notes”).
Interest payments on the 2032 Notes are due semi-annually until maturity, with the first interest payment due in January 2027. In the event of a change in control, each holder of the notes may require the Company to repurchase some or all of its notes at a repurchase price equal to 101 % of the aggregate principal amount of the notes repurchased, plus any accrued and unpaid interest. The indentures contain certain covenants that limit the ability of the Company to, among other things, (i) incur certain debt secured by liens, (ii) engage in sale and leaseback transactions and (iii) consolidate with, sell, lease, convey or otherwise transfer all or substantially all of its assets to, or merge with or into, any other person or entity. All the covenants are subject to a number of limitations and qualifications. The indentures do not require any financial covenants.
The Company recorded $6 million of debt discounts and debt issuance costs related to the 2032 Notes.
The net proceeds from the issuance have been and will be used for general corporate purposes, which may include, without limitation, refinancing of outstanding indebtedness, working capital, capital expenditures and satisfaction of other obligations.
17
Table of Contents
Other
The Company’s minimum principal payments with respect to its long-term debt obligations for the next five years are as follows ($ in millions):
From July 3, 2026 through December 31, 2026 | $ | ||||
2027 | |||||
2028 | |||||
2029 | |||||
2030 | |||||
Thereafter | |||||
NOTE 10. DERIVATIVES AND HEDGING TRANSACTIONS
On July 29, 2025, the Company entered into cross-currency swap derivative contracts with a total notional amount of $410 million to partially hedge its net investments in non-U.S. operations against adverse movements in exchange rates between the U.S. dollar and the euro and Swiss franc. These contracts are agreements to exchange fixed-rate payments in one currency for fixed-rate payments in another currency and effectively convert U.S. dollar-denominated bonds to obligations denominated in the hedged currency. These contracts also reduce the interest rate from the stated interest rates on the U.S. dollar-denominated debt to the interest rates of the swaps. The changes in the spot rate of these instruments are recorded in accumulated other comprehensive income (loss) (“OCI”) in stockholders’ equity, partially offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated OCI. The interest income or expense from these swaps is recorded in interest expense in the accompanying Consolidated Condensed Statements of Earnings consistent with the classification of interest expense attributable to the underlying debt. These instruments mature in September 2030 and September 2033.
In September 2023, the Company issued €500 million of foreign currency denominated long-term debt that is designated as a partial hedge of its net investment in foreign operations against adverse movements in exchange rates between the U.S. dollar and the euro. This foreign currency denominated long-term debt issuance is designated and qualifies as a nonderivative hedging instrument. Accordingly, the foreign currency translation of this debt instrument is recorded in accumulated OCI, offsetting the foreign currency translation adjustment of the Company’s related net investment that is also recorded in accumulated OCI. This instrument matures in September 2031.
18
Table of Contents
The following table summarizes the notional values as of July 3, 2026 and July 4, 2025 and pretax impact of changes in the fair values of instruments designated as net investment hedges in accumulated OCI for the three and six-month periods ended July 3, 2026 and July 4, 2025:
($ in millions) | Notional Amount Outstanding | Gain (Loss) Recognized in OCI | Amounts Reclassified from OCI | ||||||||||||||
For the Three-Month Period Ended July 3, 2026: | |||||||||||||||||
Net investment hedges: | |||||||||||||||||
Cross-currency contracts | $ | $ | ( | $ | |||||||||||||
Foreign currency denominated debt | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
For the Three-Month Period Ended July 4, 2025: | |||||||||||||||||
Net investment hedges: | |||||||||||||||||
Foreign currency denominated debt | $ | $ | ( | $ | |||||||||||||
For the Six-Month Period Ended July 3, 2026: | |||||||||||||||||
Net investment hedges: | |||||||||||||||||
Cross-currency contracts | $ | $ | $ | ||||||||||||||
Foreign currency denominated debt | |||||||||||||||||
Total | $ | $ | $ | ||||||||||||||
For the Six-Month Period Ended July 4, 2025: | |||||||||||||||||
Net investment hedges: | |||||||||||||||||
Foreign currency denominated debt | $ | $ | ( | $ | |||||||||||||
Gains or losses related to the net investment hedges are classified as net investment hedges adjustments in the schedule of changes in OCI in Note 12, as these items are attributable to the Company’s hedge of its net investment in foreign operations.
The Company did not reclassify any other deferred gains or losses related to the net investment hedges from accumulated other comprehensive income (loss) to earnings during the three and six-month periods ended July 3, 2026 and July 4, 2025. In addition, the Company did not have any ineffectiveness related to the net investment hedges during the three and six-month periods ended July 3, 2026 and July 4, 2025, and should they arise, any ineffective portions of the hedges would be reclassified from accumulated OCI into earnings during the period of change. The cash inflows and outflows associated with the Company’s derivative contracts designated as net investment hedges are classified in all other investing activities in the accompanying Consolidated Condensed Statements of Cash Flows, except for cash flows from the periodic interest settlements on the cross-currency swaps which are reported as cash flows from operating activities in the Consolidated Condensed Statements of Cash Flows.
19
Table of Contents
The Company’s derivative instruments, as well as its nonderivative debt instrument designated and qualifying as a net investment hedge, were classified in the Company’s Consolidated Condensed Balance Sheets as follows:
($ in millions) | July 3, 2026 | December 31, 2025 | ||||||||||||
Derivative instruments | ||||||||||||||
Derivative assets: | ||||||||||||||
Other long-term assets | $ | $ | ||||||||||||
Derivative liabilities: | ||||||||||||||
Other long-term liabilities | $ | $ | ||||||||||||
Nonderivative hedging instruments | ||||||||||||||
Long-term debt | $ | $ | ||||||||||||
NOTE 11. COMMITMENTS AND CONTINGENCIES
The Company reviews the adequacy of its legal reserves on a quarterly basis and establishes reserves for loss contingencies that are both probable and reasonably estimable. For a further description of the Company’s litigation and contingencies, refer to Note 16 of the Company’s financial statements as of and for the year ended December 31, 2025 included within the 2025 Annual Report on Form 10-K.
NOTE 12. STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION
Share Repurchase Program
On November 25, 2025, the Company announced that its Board of Directors approved a share repurchase program (the “Repurchase Program”) authorizing the repurchase of up to $750 million of the Company’s common stock from time to time on the open market (including through the use of trading plans intended to satisfy the affirmative defense conditions of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended), in privately negotiated transactions or by other methods, at the Company’s discretion. As of July 3, 2026, $317 million of the Company’s common stock remained authorized under the Repurchase Program. The program does not obligate the Company to acquire any particular amount of its common stock, has no expiration date, and will continue until otherwise suspended or terminated at any time for any reason. The timing and amount of any shares repurchased under the Repurchase Program will be determined by members of the Company’s management based on its evaluation of market, business conditions, and other factors. Refer to Part II - Item 2 for additional information.
During the three and six-month periods ended July 3, 2026, the Company repurchased approximately 2 million shares of its common stock for approximately $134 million and 5 million shares of its common stock for approximately $434 million, including related transaction costs, respectively, as part of the Repurchase Program. The Company’s common stock repurchases in excess of issuances are subject to a 1% excise tax enacted by the Inflation Reduction Act. Any excise tax incurred is recorded as part of the cost basis of the shares acquired within repurchase of common stock in the Consolidated Condensed Statements of Stockholders' Equity. The payment of the excise tax is paid annually and will be recorded within payments for repurchase of common stock in the Consolidated Condensed Statements of Cash Flows.
20
Table of Contents
Stock-Based Compensation
For a description of the stock-based compensation programs in which certain employees of the Company participate, reference is made to Note 17 of the Company’s financial statements as of and for the year ended December 31, 2025 included within the 2025 Annual Report on Form 10-K.
The Company’s stock-based compensation expense for the three-month periods ended July 3, 2026 and July 4, 2025 was $24 40
Stock-based compensation has been recognized as a component of selling, general and administrative expenses in the accompanying Consolidated Condensed Statements of Earnings. As of July 3, 2026, $62 million of total unrecognized compensation cost related to RSUs and PSUs is expected to be recognized over a weighted average period of approximately two years . As of July 3, 2026, $47 million of total unrecognized compensation cost related to stock options is expected to be recognized over a weighted average period of approximately two years . Future compensation amounts will be adjusted for any changes in estimated forfeitures.
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss) refers to certain gains and losses that under GAAP are included in comprehensive income (loss) but are excluded from net earnings as these amounts are initially recorded as an adjustment to stockholders’ equity. Foreign currency translation adjustments are generally not adjusted for income taxes as they relate to indefinite investments in non-U.S. subsidiaries. Net investment hedge adjustments reflect the gains or losses on the foreign currency denominated long-term debt issuance designated as a nonderivative hedging instrument, as well as the Company’s cross-currency swap derivatives designated as net investment hedges, net of any income tax impacts. Pension and postretirement plan benefit adjustments relate to unrecognized prior service credits and actuarial losses.
21
Table of Contents
The changes in accumulated other comprehensive income (loss) by component are summarized below:
($ in millions) | Foreign Currency Translation Adjustments | Net Investment Hedges | Pension and Postretirement Plan Benefit Adjustments | Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||
For the Three-Month Period Ended July 3, 2026: | $ | — | |||||||||||||||||||||
Balance, April 3, 2026 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||
Increase (decrease) | ( | ( | |||||||||||||||||||||
Income tax impact | ( | ( | |||||||||||||||||||||
Net other comprehensive income (loss), net of income taxes | ( | ( | |||||||||||||||||||||
Balance, July 3, 2026 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
For the Three-Month Period Ended July 4, 2025: | |||||||||||||||||||||||
Balance, April 4, 2025 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||
Increase (decrease) | ( | ||||||||||||||||||||||
Income tax impact | |||||||||||||||||||||||
Net other comprehensive income (loss), net of income taxes | ( | ||||||||||||||||||||||
Balance, July 4, 2025 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
($ in millions) | Foreign Currency Translation Adjustments | Net Investment Hedges | Pension and Postretirement Plan Benefit Adjustments | Accumulated Other Comprehensive Income (Loss) | |||||||||||||||||||
For the Six-Month Period Ended July 3, 2026: | |||||||||||||||||||||||
Balance, December 31, 2025 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||
Increase (decrease) | ( | ( | |||||||||||||||||||||
Income tax impact | ( | ( | |||||||||||||||||||||
Net other comprehensive income (loss), net of income taxes | ( | ( | |||||||||||||||||||||
Balance, July 3, 2026 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
For the Six-Month Period Ended July 4, 2025: | |||||||||||||||||||||||
Balance, December 31, 2024 | $ | ( | $ | $ | ( | $ | ( | ||||||||||||||||
Other comprehensive income (loss): | |||||||||||||||||||||||
Increase (decrease) | ( | ( | |||||||||||||||||||||
Income tax impact | |||||||||||||||||||||||
Net other comprehensive income (loss), net of income taxes | ( | ( | |||||||||||||||||||||
Balance, July 4, 2025 | $ | ( | $ | ( | $ | ( | $ | ( | |||||||||||||||
NOTE 13. RESTRUCTURING
2026 Cost Optimization Program
In April 2026, the Company announced a restructuring program (the “2026 Cost Optimization Program”) to simplify business processes and streamline our organization, optimize our cost structure, and strengthen our competitive positioning to better serve our customers.
The plan consists of (i) workforce reductions across our business and functions, (ii) site consolidations, and (iii) functional transformation initiatives.
22
Table of Contents
The 2026 Cost Optimization Program will impact corporate functions and both business segments and is expected to be substantially completed by the end of 2028.
The Company expects to incur total restructuring charges in connection with the 2026 Cost Optimization Program ranging from approximately $85 million to $105 million, with $20 million to $27 million expected to be incurred by the Water Quality segment and $60 million to $68 million expected to be incurred by the Product Quality & Innovation segment.
The following table presents the components of restructuring and transformation-related expenses which are included in the Cost of sales and Selling, general and administrative expenses line items in the Consolidated Condensed Statements of Earnings:
($ in millions) | Three-Month Period Ended | Six-Month Period Ended | |||||||||
By component: | July 3, 2026 | July 3, 2026 | |||||||||
Severance and related benefit costs: | |||||||||||
Water Quality | $ | $ | |||||||||
Product Quality & Innovation | |||||||||||
Other | |||||||||||
Total restructuring expense | $ | $ | |||||||||
The following table summarizes the activities related to the 2026 Cost Optimization Program, which are included in the Accrued expenses and other liabilities and Other long-term liabilities line items in the Consolidated Condensed Balance Sheets:
($ in millions) | Severance and related benefit costs | Asset related costs | Contract terminations | Total | |||||||||||||||||||
Balance, December 31, 2025 | $ | $ | $ | $ | |||||||||||||||||||
Restructuring charges | |||||||||||||||||||||||
Payments | ( | ( | |||||||||||||||||||||
Balance, July 3, 2026 | $ | $ | $ | $ | |||||||||||||||||||
23
Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide material information relevant to an assessment of the Company’s financial condition and results of operations, including an evaluation of the amounts and certainty of cash flows from operations and from outside sources. The MD&A is designed to focus specifically on material events and uncertainties known to management that are reasonably likely to cause reported financial information not to be necessarily indicative of future operating results or of future financial condition. This includes descriptions and amounts of matters that have had a material impact on reported operations, as well as matters that are reasonably likely based on management’s assessment to have a material impact on future operations. The Company’s MD&A is divided into five sections:
•Information Relating to Forward-Looking Statements;
•Overview;
•Results of Operations;
•Liquidity and Capital Resources; and
•Critical Accounting Estimates.
You should read this discussion along with the Company’s MD&A and audited financial statements and Notes thereto as of and for the year ended December 31, 2025, included within the 2025 Annual Report on Form 10-K, and the unaudited financial statements and related Notes as of and for the three and six-month periods ended July 3, 2026 included in this Quarterly Report on Form 10-Q (this “Report”).
INFORMATION RELATING TO FORWARD-LOOKING STATEMENTS
Certain statements included or incorporated by reference in this Report, in other documents we file with or furnish to the Securities and Exchange Commission (“SEC”), in our press releases, webcasts, conference calls, materials delivered to shareholders and other communications, are “forward-looking statements” within the meaning of the U.S. federal securities laws. All statements other than historical factual information are forward-looking statements, including without limitation statements regarding: projections of revenue, expenses, profit, profit margins, asset values, pricing, tax rates, tax provisions, cash flows, pension and benefit obligations and funding requirements, our liquidity position or other projected financial measures; management’s plans and strategies for future operations, including statements relating to anticipated operating performance, customer demand, cost reductions, restructuring activities, new product and service developments, competitive strengths or market position, acquisitions and the integration thereof, divestitures, spin-offs, split-offs, initial public offerings, other securities offerings or other distributions, strategic opportunities, stock repurchases, dividends and executive compensation; growth, declines and other trends in markets we sell into, the impact of global trade policies, tariffs, restrictions on imports, related countermeasures and reciprocal tariffs; future new or modified laws, regulations, accounting pronouncements or public policy changes; future regulatory approvals and the timing and conditionality thereof; outstanding claims, legal proceedings, tax audits and assessments and other contingent liabilities; future foreign currency exchange rates and fluctuations in those rates; results of operations and/or financial condition; general economic and capital markets conditions; the anticipated timing of any of the foregoing; assumptions underlying any of the foregoing; and any other statements that address events or developments that Veralto intends or believes will or may occur in the future. Terminology such as “believe,” “anticipate,” “assume,” “continue,” “should,” “could,” “intend,” “will,” “plan,” “aim,” “expect,” “estimate,” “project,” “target,” “can,” “may,” “possible,” “potential,” “upcoming,” “forecast” and “positioned” and similar references to future periods are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Forward-looking statements are based on assumptions and assessments made by our management in light of their experience and perceptions of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to the risks and uncertainties set forth below and under “Item 1A. Risk Factors” in the 2025 Annual Report on Form 10-K and any subsequent updates in “Item 1A. Risk Factors” within Quarterly Reports on Form 10-Q.
Forward-looking statements are not guarantees of future performance and actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Accordingly, you should not place undue reliance on any such forward-looking statements. Forward-looking statements speak only as of the date of the report, document, press release, webcast, call, materials or other communication in which
24
Table of Contents
they are made. Except to the extent required by applicable law, we do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.
Below is a summary of material risks and uncertainties we face, some of which we have experienced and any of which may occur in the future. These risks are discussed more fully in “Item 1A. Risk Factors” in the 2025 Annual Report on Form 10-K and any subsequent updates in “Item 1A. Risk Factors” within Quarterly Reports on Form 10-Q:
Business and Strategic Risks
•Conditions in the global economy, including the current conflict in the Middle East and changes in trade and tariff policies, the particular markets we serve and the financial markets can adversely affect our business and financial statements.
•The U.S. government has imposed and may continue to impose significant tariffs or other restrictions on foreign imports, and such trade restrictions or related countermeasures taken by impacted foreign countries could adversely affect our business and financial statements.
•We face intense competition and if we are unable to compete effectively, we may experience decreased demand and decreased market share. Even if we compete effectively, we may be required to reduce the prices we charge.
•Our growth depends on the timely development and commercialization, and customer acceptance, of new and enhanced products and services based on technological innovation.
•Uncertainties with respect to the development, deployment, and use of artificial intelligence in our business and products may adversely affect our business and financial statements.
•Non-U.S. economic, political, legal, compliance, social and business factors can adversely affect our business and financial statements.
•Our growth can also suffer if the markets into which we sell our products and services decline, do not grow as anticipated or experience cyclicality.
Acquisitions, Divestitures and Investment Risks
•Any inability to consummate acquisitions at our historical rate and appropriate prices, and to make appropriate investments that support our long-term strategy, could negatively impact our business. Our acquisition of businesses, investments, or other strategic relationships could also negatively impact our business and financial statements and our indemnification or insurance rights may not fully protect us from liabilities related thereto.
•Divestitures or other dispositions could adversely affect our business and financial statements.
Operational Risks
•Significant disruptions in, or breaches in security of, our information technology (“IT”) systems or data or violations of data privacy laws can adversely affect our business and financial statements.
•Defects and unanticipated use or inadequate disclosure with respect to our products or services, or allegations thereof, can adversely affect our business and financial statements.
•If we suffer loss to our facilities, supply chains, distribution systems or information technology systems due to catastrophe or other events, our operations could be seriously harmed.
•Climate change and sustainability matters, legal or regulatory measures to address climate change and sustainability matters, and any inability on our part to address related stakeholder expectations may negatively affect us.
•Our financial results are subject to fluctuations in the cost and availability of the supplies that we use in, and the labor we need for, our operations.
25
Table of Contents
•Our success depends on our ability to recruit, retain and motivate talented employees representing diverse backgrounds, experiences and skill sets.
•Our restructuring actions could result in unexpected costs, may not achieve the anticipated benefits and can have long-term adverse effects on our business and financial statements.
Intellectual Property Risks
•If we are unable to adequately protect our intellectual property, or if third parties infringe our intellectual property rights, we may suffer competitive injury or expend significant resources enforcing our rights. These risks are particularly pronounced in countries in which we do business that do not have levels of protection of intellectual property comparable to the United States.
•Third parties from time to time claim that we are infringing or misappropriating their intellectual property rights and we could suffer significant litigation expenses, losses or licensing expenses or be prevented from selling products or services.
Financial and Tax Risks
•Our existing and future indebtedness may limit our operations and our use of our cash flow and negatively impact our credit ratings; and any failure to comply with the covenants that apply to our indebtedness could adversely affect our business and financial statements.
•We may be required to recognize impairment charges for our goodwill and other intangible assets.
•Foreign currency exchange rates can adversely affect our financial statements.
•Changes in our tax rates or exposure to additional income tax liabilities or assessments could affect our earnings. In addition, challenges to tax positions taken through audits by tax authorities could result in additional tax payments for prior periods.
•Changes in tax law relating to multinational corporations could adversely affect our tax position.
Legal, Regulatory, Compliance and Reputational Risks
•Our businesses are subject to extensive regulation, and failure to comply with those regulations could adversely affect our business and financial statements.
•We are subject to or otherwise responsible for a variety of litigation and other legal and regulatory proceedings in the course of our business that can adversely affect our business and financial statements.
•Our operations, products and services expose us to the risk of environmental, health and safety liabilities, costs and violations that could adversely affect our business and financial statements.
•Certain provisions in Veralto’s certificate of incorporation and bylaws, and of Delaware law, may prevent or delay an acquisition of Veralto, which could decrease the trading price of Veralto’s common stock.
•The forum selection provisions under Veralto’s certificate of incorporation could discourage lawsuits against Veralto and Veralto’s directors, officers, employees and stockholders.
•If we are unable to maintain effective internal control over financial reporting in the future, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock may be negatively affected.
See “Item 1A. Risk Factors” in the 2025 Annual Report on Form 10-K and any subsequent updates in “Item 1A. Risk Factors” within Quarterly Reports on Form 10-Q for further discussion regarding reasons that actual results may differ materially from the results, developments and business decisions contemplated by our forward-looking statements. Forward-looking statements speak only as of the date of the report, document, press release, webcast, call, materials or other communication in which they are made. Except to the extent required by applicable law, we do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.
26
Table of Contents
OVERVIEW
Business Overview
Veralto Corporation’s unifying purpose is Safeguarding the World’s Most Vital ResourcesTM. Our diverse group of leading operating companies provides essential technology solutions that monitor, enhance and protect key resources around the globe. We are committed to the advancement of public health and safety and believe we are positioned to support our customers as they address large global challenges including environmental resource sustainability, water scarcity, management of severe weather events, food and pharmaceutical security, and the impact of an aging workforce. For decades, we have used our scientific expertise and innovative technologies to address complex challenges our customers face across regulated industries – including municipal utilities, food and beverage, pharmaceutical and industrials – where the consequence of failure is high. Through our core offerings in water analytics, water treatment, marking and coding, and packaging and color, customers look to our solutions to help ensure the safety, quality, efficiency and reliability of their products, processes and people globally. Veralto is headquartered in Waltham, Massachusetts with a workforce of nearly 17,000 employees (whom we refer to as “associates”) as of December 31, 2025, strategically located in approximately 50 countries.
Veralto Corporation is a Delaware corporation and was incorporated in 2023 in connection with the separation of Veralto from Danaher Corporation (“Danaher”) on September 30, 2023 as an independent, publicly traded company, listed on the New York Stock Exchange (the “Separation”).
Veralto operates through two segments – Water Quality (“WQ”) and Product Quality & Innovation (“PQI”). Our businesses within these segments have strong globally recognized brands as a result of our leadership in served markets over several decades. Our WQ segment provides innovative products and services that improve the quality and reliability of water with leading brands including Hach, Trojan Technologies and ChemTreat. Our PQI segment enables our customers to promote consumer trust in their products and help enable product innovation with leading brands including Videojet, Linx, Esko, X-Rite and Pantone. We believe our leading positions result from the strength of our commercial organizations, our legacy of innovation, and our close and long-term connectivity to our customers and knowledge of their workflows, underpinned by our culture of continuous improvement. This has resulted in a large installed base of instruments that drive ongoing consumables and software sales to support our customers. As a result, our business generates recurring sales which represented approximately 62% of total sales during the six-month period ended July 3, 2026. Our business model also supports a strong margin profile with limited capital expenditure requirements and has generated attractive cash flows. We believe these attributes allow us to deliver financial performance that is resilient across economic cycles.
As a result of our geographic and industry diversity, Veralto faces a variety of opportunities and challenges, including rapid technological development in most of our served markets, the expansion and evolution of high-growth markets, trends and costs associated with a global labor force, consolidation of our competitors and increasing regulation. Veralto operates in a highly competitive business environment in most markets, and our long-term growth and profitability will depend in particular on our ability to identify, consummate and integrate appropriate acquisitions and identify and consummate appropriate investments and strategic partnerships, develop innovative and differentiated new products and services with higher gross profit margins, expand and improve the effectiveness of our sales force, continue to reduce costs and improve operating efficiency and quality, effectively address the demands of an increasingly regulated global environment and expand our business in high-growth geographies and high-growth market segments. We are making significant investments, organically and through acquisitions and investments, to address the rapid pace of technological change in our served markets and to globalize our manufacturing, research and development and customer-facing resources to be responsive to our customers throughout the world and improve the efficiency of our operations. We define high-growth markets as developing markets of the world which include Asia (with the exception of Japan, Australia and New Zealand), Latin America (including Mexico), the Middle East, Eastern Europe and Africa. We define developed markets as all markets of the world that are not high-growth markets.
We also believe that the Veralto Enterprise System (“VES”) provides us with a strong foundation for competitive differentiation. VES is a business management system that consists of a philosophy, processes and tools that guide what Veralto does and measure how well Veralto executes, grounded in a culture of continuous improvement. VES processes and tools are organized around the areas of Operational Excellence, Growth and Leadership, and are rooted in foundational tools known as the VES Fundamentals, which are relevant to every associate and business function. The VES Fundamentals are focused on core competencies such as using visual representations of processes to identify inefficiencies, creating standard work, defining and solving problems in a structured way, and continuously improving processes to drive long-term impact.
27
Table of Contents
Veralto uses VES tools to improve our profitability and cash flows, which support our ability to expand our addressable market and improve our market position through investments in areas such as our commercial organization and research and development (“R&D”), including software and digital solutions. Our cash flows also support acquisitions to enhance our product capabilities and expansion into new and attractive markets, which we have successfully done through the acquisition of over 85 businesses over more than two decades.
Business Performance
During the three-month period ended July 3, 2026, overall revenues increased 7.6% and core sales increased 4.2% compared to the comparable period in 2025 primarily driven by core sales growth in the Water Quality segment. Currency exchange rates and acquisitions, net of divestitures increased reported sales by 1.0% and 2.4%, respectively, during the three-month period ended July 3, 2026 compared to the comparable period in 2025. For the six-month period ended July 3, 2026, overall revenues increased 7.1% and core sales increased 3.1%, compared to the comparable period in 2025. Currency exchange rates and acquisitions, net of divestitures increased reported sales by 2.2% and 1.8%, respectively, during the six-month period ended July 3, 2026 compared to the comparable period in 2025. For the definition of “core sales” refer to “—Results of Operations” below.
Geographically, the Company’s sales during the three-month period ended July 3, 2026 in developed markets increased year-over-year by 9.3%, driven by increased sales of 9.2% in North America, 9.0% in Western Europe, and 13.8% in other developed markets. Sales in high-growth markets increased 2.9% year-over-year. For the same period, core sales in developed markets increased 6.3% driven by increased core sales of 7.0% in North America and increased core sales of 4.9% in Western Europe. Core sales in high-growth markets decreased 0.1%, driven by a low-single digit decreases in Latin America and in China.
Geographically, the Company’s sales during the six-month period ended July 3, 2026 in developed markets increased year-over-year by 8.5%, driven by increased sales of 7.5% in North America, 10.6% in Western Europe, and 8.6% in other developed markets. Sales in high-growth markets increased 3.5% year-over-year. For the same period, core sales in developed markets increased 4.7% driven by increased core sales of 5.8% in North America and increased core sales of 2.7% in Western Europe. Core sales in high-growth markets decreased 0.3%, driven by low-single digit decreases in Latin America.
The Company’s net earnings for the three and six-month periods ended July 3, 2026 totaled $241 million and $495 million, respectively, compared to $222 million and $447 million, respectively, for the three and six-month periods ended July 4, 2025. The increase in net earnings was primarily driven by increased sales resulting from positive pricing actions, the impact of acquisitions, and the positive impact of recoveries of tariffs previously collected under the International Emergency Economic Powers Act (“IEEPA”), partially offset by higher cost of sales and restructuring costs related to the 2026 Cost Optimization Program. Refer to “—Results of Operations” for further discussion of the year-over-year changes in net earnings for the three and six-month periods ended July 3, 2026.
Outlook
Water Quality: we continue to expect global growth led by positive secular growth drivers across municipal and industrial markets globally, and disciplined commercial execution. Segment performance is expected to benefit from steady municipal demand driven by recurring revenue from a large installed base, while industrial demand is driven by regional end-market dynamics.
Product Quality & Innovation: we expect growth to accelerate as the year progresses, driven by steady demand from consumer packaged goods market globally and increasing adoption of digital workflow solutions. Performance is expected to benefit from steady recurring revenue from a large installed base, new product offerings that help our customers convey the quality and safety of their products and build trust with consumers, and recovery in certain industrial end-markets in second half of the year.
The potential effects of tariffs, prospective changes in trade policies and conflict in the Middle East remain uncertain. The Company’s objective is to implement appropriate countermeasures designed to mitigate the impact of these items, and other forms of macroeconomic volatility. Regardless of market conditions, the Company leverages VES to support its customers, promote growth and drive continuous improvement.
The Company’s ability to meet its expectations is subject to numerous risks, including, but not limited to, those described in “Item 1A. Risk Factors” within the Company’s 2025 Annual Report on Form 10-K and any subsequent updates in “Item 1A. Risk Factors” within Quarterly Reports on Form 10-Q.
28
Table of Contents
Acquisitions
On January 22, 2026, the Company completed the acquisition of In-Situ, Inc. (“In-Situ”), for a cash purchase price of approximately $426 million, net of cash acquired. In-Situ is a global leader in environmental water measurement and monitoring solutions with a leading portfolio of water quality sondes, water quality sensors and data management solutions that help customers monitor and measure the quality or quantity of surface and groundwater. In-Situ has been integrated into the Water Quality segment.
On April 7, 2026, the Company completed the acquisition of GlobalVision, for a cash purchase price of approximately CAD $270 million ($195 million), net of cash acquired. GlobalVision leverages its core proprietary deterministic technology with AI-augmented functionality to help pharmaceutical and consumer-packaged goods customers accelerate their speed to market and meet critical quality and packaging compliance regulations, verifying that packaging content remains accurate and compliant at every critical hand-off. GlobalVision will be integrated into the Product Quality & Innovation segment.
RESULTS OF OPERATIONS
Non-GAAP Measures
In this Report, references to the non-GAAP measure of core sales refer to sales from continuing operations calculated according to GAAP but excluding sales from acquired (or divested) businesses (as defined below, as applicable) and the impact of currency translation.
References to sales or operating profit attributable to acquisitions or acquired businesses refer to sales or operating profit, as applicable, from acquired businesses recorded prior to the first anniversary of the acquisition less any sales and operating profit, during the applicable period, attributable to divested product lines not considered discontinued operations. The portion of revenue attributable to currency translation is calculated as the difference between the period-to-period change in revenue (excluding sales from acquired/divested businesses (as defined above, as applicable)) and the period-to-period change in revenue (excluding sales from acquired/divested businesses (as defined above, as applicable)) after applying current period foreign exchange rates to the prior year period.
Core sales growth should be considered in addition to, and not as a replacement for or superior to, sales growth, and may not be comparable to similarly titled measures reported by other companies. Management believes that reporting the non-GAAP financial measure of core sales growth provides useful information to investors by helping identify underlying growth trends in the Company’s business and facilitating comparisons of the Company’s revenue performance with its performance in prior and future periods and to the Company’s peers. Management also uses core sales growth to measure the Company’s operating and financial performance and as one of the performance measures in the Company’s short-term incentive compensation program. The Company excludes the effect of currency translation from core sales because currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends, and excludes the effect of acquisitions and divestiture-related items because the nature, size, timing and number of acquisitions and divestitures can vary dramatically from period-to-period and between the Company and its peers, and can also obscure underlying business trends and make comparisons of long-term performance difficult.
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of each non-GAAP financial measure to its most directly comparable GAAP financial measure.
Sales Growth and Core Sales Growth
% Change Three-Month Period Ended July 3, 2026 vs. Comparable 2025 Period | % Change Six-Month Period Ended July 3, 2026 vs. Comparable 2025 Period | ||||||||||
Total sales growth (GAAP) | 7.6 | % | 7.1 | % | |||||||
Impact of: | |||||||||||
Acquisitions/divestitures | (2.4) | % | (1.8) | % | |||||||
Currency exchange rates | (1.0) | % | (2.2) | % | |||||||
Core sales growth (non-GAAP) | 4.2 | % | 3.1 | % | |||||||
29
Table of Contents
2026 Sales Compared to 2025
Total sales increased 7.6% and 7.1% during the three and six-month periods ended July 3, 2026, respectively, compared to the comparable periods in 2025, primarily as a result of core sales growth driven by the factors discussed below by segment.
Currency exchange rates and acquisitions, net of divestitures, increased reported sales by 1.0% and 2.4%, respectively, during the three-month period ended July 3, 2026, compared to the comparable period in 2025. Currency exchange rates and acquisitions, net of divestitures, increased reported sales by 2.2% and 1.8%, respectively, during the six-month period ended July 3, 2026, compared to the comparable period in 2025. Price increases contributed 3.0% and 2.4% to sales growth on a year-over-year basis during the three and six-month periods ended July 3, 2026, respectively, and are reflected as a component of core sales growth above.
Business Segments
Sales by business segment for each of the periods indicated were as follows:
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
($ in millions) | July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | |||||||||||||||||||
Water Quality | $ | 908 | $ | 825 | $ | 1,782 | $ | 1,619 | |||||||||||||||
Product Quality & Innovation | 566 | 546 | 1,114 | 1,084 | |||||||||||||||||||
Total | $ | 1,474 | $ | 1,371 | $ | 2,896 | $ | 2,703 | |||||||||||||||
For information regarding the Company’s sales by geographical region, refer to Note 4 to the accompanying Consolidated Condensed Financial Statements.
Cost of Sales and Gross Profit
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
($ in millions) | July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | |||||||||||||||||||
Sales | $ | 1,474 | $ | 1,371 | $ | 2,896 | $ | 2,703 | |||||||||||||||
Cost of sales | (572) | (549) | (1,140) | (1,076) | |||||||||||||||||||
Gross profit | $ | 902 | $ | 822 | $ | 1,756 | $ | 1,627 | |||||||||||||||
Gross profit margin | 61.2 | % | 60.0 | % | 60.6 | % | 60.2 | % | |||||||||||||||
Cost of sales increased by $23 million or 4.2% and by $64 million or 5.9% on a year-over-year basis during the three and six-month periods ended July 3, 2026, respectively, as compared to the comparable periods in 2025, driven primarily by higher year-over-year sales volumes, increased labor costs and price increases due to inflation.
Gross profit margins increased 120 basis points on a year-over-year basis during the three-month period ended July 3, 2026, as compared to the comparable period in 2025, driven by positive pricing actions, the impact of improved labor overhead and productivity, recoveries of tariffs previously collected under IEEPA, and the net positive impact from the gross profit margin of recent acquisitions, partially offset by increased labor costs and price increases due to inflation. Gross profit margins increased 40 basis points on a year-over-year basis during the six-month period ended July 3, 2026, as compared to the comparable period in 2025, driven by positive pricing actions, the impact of foreign currency exchange rates, recoveries of tariffs previously collected under IEEPA, and the net positive impact from the gross profit margin of recent acquisitions.
Operating Expenses
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
($ in millions) | July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | |||||||||||||||||||
Sales | $ | 1,474 | $ | 1,371 | $ | 2,896 | $ | 2,703 | |||||||||||||||
Selling, general and administrative (“SG&A”) expenses | (514) | (442) | (962) | (861) | |||||||||||||||||||
Research and development (“R&D”) expenses | (73) | (67) | (141) | (131) | |||||||||||||||||||
SG&A as a % of sales | 34.9 | % | 32.2 | % | 33.2 | % | 31.9 | % | |||||||||||||||
R&D as a % of sales | 5.0 | % | 4.9 | % | 4.9 | % | 4.8 | % | |||||||||||||||
30
Table of Contents
SG&A expenses as a percentage of sales increased 270 bps and 130 bps during the three and six-month periods ended July 3, 2026, respectively, as compared to the comparable periods in 2025, driven primarily by restructuring costs related to the 2026 Cost Optimization Program, incremental labor costs, and sales and marketing growth initiatives.
R&D expenses as a percentage of sales were essentially flat during the three and six-month periods ended July 3, 2026 as compared to the comparable periods in 2025.
Operating Profit Performance
Operating profit margins were 21.4% for the three-month period ended July 3, 2026 as compared to 22.8% for the three-month period ended July 4, 2025. The following factors impacted year-over-year operating profit margin comparisons:
Second quarter 2026 vs. second quarter 2025 operating profit margin comparisons were unfavorably impacted by:
•Restructuring charges incurred related to the 2026 Cost Optimization Program - 200 bps
•Costs incurred in the second quarter of 2026 related to certain strategic initiatives, including transaction costs incurred related to the acquisition of GlobalVision - 20 basis points
•The net dilutive impact during 2026 of acquisitions and dispositions - 20 basis points
Second quarter 2026 vs. second quarter 2025 operating profit margin comparisons were favorably impacted by:
•Transaction costs incurred during the second quarter of 2025 related to certain strategic initiatives - 10 basis points
•Higher second quarter 2026 core sales and recoveries of tariffs previously collected under IEEPA, partially offset by incremental labor costs and sales and marketing growth initiatives - 90 basis points
Operating profit margins were 22.5% for the six-month period ended July 3, 2026 as compared to 23.5% for the six-month period ended July 4, 2025. The following factors impacted year-over-year operating profit margin comparisons:
Year-to-date 2026 vs. year-to-date 2025 operating profit margin comparisons were unfavorably impacted by:
•Restructuring charges related to the 2026 Cost Optimization Program - 100 basis points
•Costs incurred in 2026 related to certain strategic initiatives, including transaction costs incurred related to the acquisitions of In-Situ and GlobalVision - 30 basis points
•The net dilutive impact during 2026 of acquisitions and dispositions - 10 basis points
Year-to-date 2026 vs. year-to-date 2025 operating profit margin comparisons were favorably impacted by:
•Transaction costs incurred during the first two quarters of 2025 related to certain strategic initiatives - 10 basis points
•Higher 2026 core sales and recoveries of tariffs previously collected under IEEPA, partially offset by incremental labor costs and sales and marketing growth initiatives - 30 basis points
WATER QUALITY
The Company’s Water Quality segment provides proprietary precision instrumentation, consumables, software, services and advanced water treatment technologies to help measure, analyze and treat the world’s water in municipal, industrial, commercial, residential, research and natural resource applications.
31
Table of Contents
Water Quality Selected Financial Data
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
($ in millions) | July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | |||||||||||||||||||
Sales | $ | 908 | $ | 825 | $ | 1,782 | $ | 1,619 | |||||||||||||||
Operating profit | 228 | 211 | 438 | 409 | |||||||||||||||||||
Depreciation | 8 | 7 | 15 | 13 | |||||||||||||||||||
Amortization of intangible assets | 8 | 3 | 15 | 5 | |||||||||||||||||||
Operating profit as a % of sales | 25.1 | % | 25.6 | % | 24.6 | % | 25.3 | % | |||||||||||||||
Depreciation as a % of sales | 0.9 | % | 0.8 | % | 0.8 | % | 0.8 | % | |||||||||||||||
Amortization as a % of sales | 0.9 | % | 0.4 | % | 0.8 | % | 0.3 | % | |||||||||||||||
Sales Growth and Core Sales Growth
% Change Three-Month Period Ended July 3, 2026 vs. Comparable 2025 Period | % Change Six-Month Period Ended July 3, 2026 vs. Comparable 2025 Period | ||||||||||
Total sales growth (GAAP) | 10.1 | % | 10.1 | % | |||||||
Impact of: | |||||||||||
Acquisitions/divestitures | (3.2) | % | (3.1) | % | |||||||
Currency exchange rates | (1.2) | % | (2.2) | % | |||||||
Core sales growth (non-GAAP) | 5.7 | % | 4.8 | % | |||||||
Total Water Quality segment sales increased 10.1% year-over-year during the three and six-month periods ended July 3, 2026 as compared to the comparable period in 2025, primarily as a result of core sales growth driven by the factors discussed below. Geographically, sales growth was driven by North America, which saw increases of 10.8% and 9.4%, and Western Europe, which saw increases of 14.8% and 17.6% for the three and six-month periods ended July 3, 2026, respectively, compared to the comparable periods in 2025. Sales in high-growth markets increased 3.7% and 5.6% during the three and six-month periods ended July 3, 2026, respectively, compared to the comparable periods in 2025.
Price increases in the segment contributed 2.9% and 2.4% to sales growth on a year-over-year basis during the three and six-month periods ended July 3, 2026, respectively, and are reflected as a component of the change in core sales growth.
Core sales in the Water Quality segment increased 5.7% and 4.8% year-over-year during the three and six-month periods ended July 3, 2026, respectively. Geographically, core sales growth was driven by increases of 8.3% in North America and 9.3% in Western Europe during the three-month period ended July 3, 2026 compared to the comparable period in 2025. For the same period, core sales in high-growth markets decreased 1.5%, driven by mid-single digit decreases in Latin America and low-single digit decreases in China. Geographically, core sales growth was driven by increased core sales of 7.0% in North America and 6.9% in Western Europe during the six-month period ended July 3, 2026 compared to the comparable period in 2025. For the same period, core sales in high-growth markets decreased 0.6%, driven by mid-single digit decreases in Latin America and low-single digit decreases in China.
The increase in core sales during the three and six-month periods ended July 3, 2026 was driven by the chemical treatment solutions business and, to a lesser extent, the analytical instrumentation business. Core sales in the chemical treatment solutions business increased 10.7% and 7.4% year-over-year in the three and six-month periods ended July 3, 2026, respectively, as a result of increased core sales across North America. Core sales in the analytical instrumentation business increased 2.8% and 2.7% year-over-year for the three and six-month periods ended July 3, 2026, as a result of increased core sales across Western Europe and North America.
Operating Profit Performance
Operating profit margins were 25.1% for the three-month period ended July 3, 2026 as compared to 25.6% for the three-month period ended July 4, 2025. The following factors impacted year-over-year operating profit margin comparisons:
32
Table of Contents
Second quarter 2026 vs. second quarter 2025 operating profit margin comparisons were unfavorably impacted by:
•Restructuring charges related to the 2026 Cost Optimization Program - 60 basis points
•The net dilutive impact during 2026 of acquisitions and dispositions - 40 basis points
Second quarter 2026 vs. second quarter 2025 operating profit margin comparisons were favorably impacted by:
•Higher second quarter 2026 core sales and recoveries of tariffs previously collected under IEEPA, partially offset by incremental labor costs and sales and marketing growth initiatives - 50 basis points
Operating profit margins were 24.6% for the six-month period ended July 3, 2026 as compared to 25.3% for the six-month period ended July 4, 2025. The following factors impacted year-over-year operating profit margin comparisons:
Year-to-date 2026 vs. year-to-date 2025 operating profit margin comparisons were unfavorably impacted by:
•Restructuring charges related to the 2026 Cost Optimization Program - 30 basis points
•The net dilutive impact during 2026 of acquisitions and dispositions - 30 basis points
•Costs incurred in 2026 related to certain strategic initiatives, including transaction costs incurred related to the acquisition of In-Situ - 20 basis points
•Acquisition-related fair value adjustment to inventory related to the acquisition of In-Situ - 10 basis points
Year-to-date 2026 vs. year-to-date 2025 operating profit margin comparisons were favorably impacted by:
•Higher 2026 core sales and recoveries of tariffs previously collected under IEEPA, partially offset by incremental labor costs - 20 basis points
PRODUCT QUALITY & INNOVATION
The Company’s Product Quality & Innovation segment provides equipment, consumables, software and services for various marking and coding, traceability, printing, packaging design and quality management, packaging converting and color and appearance management applications for consumer-packaged goods and industrial products.
Product Quality & Innovation Selected Financial Data
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
($ in millions) | July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | |||||||||||||||||||
Sales | $ | 566 | $ | 546 | $ | 1,114 | $ | 1,084 | |||||||||||||||
Operating profit | 119 | 134 | 263 | 280 | |||||||||||||||||||
Depreciation | 4 | 3 | 8 | 7 | |||||||||||||||||||
Amortization of intangible assets | 9 | 6 | 15 | 13 | |||||||||||||||||||
Operating profit as a % of sales | 21.0 | % | 24.5 | % | 23.6 | % | 25.8 | % | |||||||||||||||
Depreciation as a % of sales | 0.7 | % | 0.5 | % | 0.7 | % | 0.6 | % | |||||||||||||||
Amortization as a % of sales | 1.6 | % | 1.1 | % | 1.3 | % | 1.2 | % | |||||||||||||||
Sales Growth and Core Sales Growth
% Change Three-Month Period Ended July 3, 2026 vs. Comparable 2025 Period | % Change Six-Month Period Ended July 3, 2026 vs. Comparable 2025 Period | ||||||||||
Total sales growth (GAAP) | 3.8 | % | 2.8 | % | |||||||
Impact of: | |||||||||||
Acquisitions/divestitures | (1.2) | % | — | % | |||||||
Currency exchange rates | (0.6) | % | (2.3) | % | |||||||
Core sales growth (non-GAAP) | 2.0 | % | 0.5 | % | |||||||
33
Table of Contents
Total Product Quality & Innovation segment sales increased 3.8% and 2.8% year-over-year during the three and six-month periods ended July 3, 2026, respectively, primarily as a result of changes in core sales driven by the factors discussed below. Geographically, sales growth was driven by North America, which saw increases of 4.9% and 2.7%, and Western Europe, which saw increases of 3.7% and 4.3% during the three and six-month periods ended July 3, 2026, respectively, compared to the comparable periods in 2025. Sales in high-growth markets increased 2.1% and 1.4% during the three and six-month periods ended July 3, 2026, respectively, compared to the comparable periods in 2025.
Price increases in the segment contributed 3.0% and 2.5% to sales growth on a year-over-year basis during the three and six-month periods ended July 3, 2026, respectively, and are reflected as a component of the change in core sales described below.
Core sales in the Product Quality & Innovation segment increased 2.0% and 0.5% year-over-year during the three and six-month periods ended July 3, 2026, respectively. Geographically, the change in core sales was driven by increases of 3.7% in North America and increases of 0.8% in Western Europe during the three-month period ended July 3, 2026 compared to the comparable period in 2025. For the same period, core sales in high-growth markets increased 1.4%, driven by increases in certain Asian markets, partially offset by low-single digit decreases in China and Latin America. Geographically, the change in core sales was driven by increases of 2.4% in North America partially offset by decreases of 1.2% in Western Europe during the six-month period ended July 3, 2026 compared to the comparable period in 2025. For the same period, core sales in high-growth markets were flat, driven by low-single digit decreases in Latin America offset by mid-single digit increases in China.
From a product line perspective, core sales in the marking and coding business increased 3.5% and 2.8% year-over-year during the three and six-month periods ended July 3, 2026, respectively, driven by demand across most major end-markets and geographies. Core sales in the packaging and color solutions business decreased 1.4% and 4.4% year-over-year during the three and six-month periods ended July 3, 2026, respectively, due to the impact of global macroeconomic conditions on certain product lines.
Operating Profit Performance
Operating profit margins were 21.0% for the three-month period ended July 3, 2026 as compared to 24.5% for the three-month period ended July 4, 2025. The following factors impacted year-over-year operating profit margin comparisons:
Second quarter 2026 vs. second quarter 2025 operating profit margin comparisons were unfavorably impacted by:
•Restructuring charges related to the 2026 Cost Optimization Program - 380 basis points
•Transaction costs incurred during the second quarter of 2026 related to the acquisition of GlobalVision - 50 basis points
Second quarter 2026 vs. second quarter 2025 operating profit margin comparisons were favorably impacted by:
•Higher 2026 core sales and recoveries of tariffs previously collected under IEEPA, partially offset by incremental labor costs and sales and marketing growth initiatives - 80 basis points
Operating profit margins were 23.6% for the six-month period ended July 3, 2026 as compared to 25.8% for the six-month period ended July 4, 2025. The following factors impacted year-over-year operating profit margin comparisons:
Year-to-date 2026 vs. year-to-date 2025 operating profit margin comparisons were unfavorably impacted by:
•Restructuring charges related to the 2026 Cost Optimization Program - 190 basis points
•Transaction costs incurred during 2026 related to the acquisition of GlobalVision - 50 basis points
Year-to-date 2026 vs. year-to-date 2025 operating profit margin comparisons were favorably impacted by:
•The net impact in 2026 of acquisitions and dispositions - 10 basis points
•Higher 2026 core sales and recoveries of tariffs previously collected under IEEPA, partially offset by incremental labor costs and sales and marketing growth initiatives - 10 basis points
34
Table of Contents
OTHER INCOME (EXPENSE), NET
Other income (expense), net included a pre-tax gain of $7 million from the step acquisition of our previously held minority ownership interest in In-Situ during the six-month period ended July 3, 2026, and a loss on the disposition of a product line of $6 million during the six-month period ended July 4, 2025.
INTEREST COSTS AND FINANCING
For a discussion of the Company’s outstanding indebtedness, refer to Note 9 to the accompanying Consolidated Condensed Financial Statements.
Net interest expense of $27 million and $51 million was recorded for the three and six-month periods ended July 3, 2026, respectively, compared to net interest expense of $28 million and $55 million for the three and six-month periods ended July 4, 2025, respectively, primarily arising from our outstanding indebtedness.
INCOME TAXES
General
Income tax expense and deferred tax assets and liabilities reflect management’s assessment of future taxes expected to be paid on items reflected in the Company’s Consolidated Condensed Financial Statements. The Company records the tax effect of discrete items and items that are reported net of their tax effects in the period in which they occur.
The Company’s effective tax rate can be impacted by changes in the mix of earnings in countries with different statutory tax rates, changes in the valuation of deferred tax assets and liabilities, accruals related to contingent tax liabilities and period-to-period changes in such accruals, the results of audits and examinations of previously filed tax returns (as discussed below), the expiration of statutes of limitations, the implementation of tax planning strategies, tax rulings, court decisions, and changes in tax laws and regulations, and legislative policy changes. For a description of the tax treatment of earnings that are planned to be reinvested indefinitely outside the United States, refer to “Liquidity and Capital Resources” below.
The following table summarizes the Company’s effective tax rate:
Three-Month Period Ended | Six-Month Period Ended | ||||||||||||||||||||||
July 3, 2026 | July 4, 2025 | July 3, 2026 | July 4, 2025 | ||||||||||||||||||||
Effective tax rate | 16.6 | % | 22.1 | % | 18.9 | % | 22.1 | % | |||||||||||||||
Year-Over-Year Changes in the Tax Provision and Effective Tax Rate The Company operates globally, including in certain jurisdictions with higher statutory tax rates than the United States (“U.S.”). Therefore, based on earnings mix, the impact of operating in such jurisdictions may contribute to a higher effective tax rate compared to the U.S. federal statutory tax rate.
The effective tax rate for the three-month period ended July 3, 2026 differs from the U.S. federal statutory rate of 21% principally due to the geographic mix of earnings described above, the favorable impact of tax law changes under the One Big Beautiful Bill Act (“OBBBA”), a net discrete benefit of $12 million related primarily to the impact of restructuring costs and amended return filings. The net discrete benefit decreased the effective tax rate by 2.9% for the three-month period ended July 3, 2026.
The effective tax rate for the six-month period ended July 3, 2026 differs from the U.S. federal statutory rate of 21% principally due to the geographic mix of earnings described above, the favorable impact of tax law changes under the One Big Beautiful Bill Act (“OBBBA”), a net discrete benefit of $10 million related primarily to the impact of restructuring costs and amended return filings. The net discrete benefit decreased the effective tax rate by 0.6% for the six-month period ended July 3, 2026.
The effective tax rate for the three-month period ended July 4, 2025 differs from the U.S. federal statutory rate of 21% principally due to the geographic mix of earnings described above.
The effective tax rate for the six-month period ended July 4, 2025 differs from the U.S. federal statutory rate of 21% principally due to the geographic mix of earnings described above, the unfavorable impact of a non-deductible loss on the sale of a product line of $2 million, and a net discrete benefit of $2 million related primarily to the impact of excess tax benefits from stock-based compensation, partially offset by the impact of uncertain tax positions. The net discrete benefit decreased the effective tax rate by 0.3% for the six-month period ended July 4, 2025.
35
Table of Contents
The Company conducts business globally, requiring filing numerous consolidated and separate income tax returns in the U.S. federal and state and non-U.S. jurisdictions. The non-U.S. countries in which the Company has a significant presence include Belgium, Brazil, Canada, China, Germany, the Netherlands and the United Kingdom. Excluding these non-U.S. jurisdictions, the Company believes that a change in the statutory tax rate of any individual non-U.S. country would not have a material effect on the Company’s Consolidated Condensed Financial Statements given the geographic dispersion of the Company’s income.
The Company is routinely examined by various domestic and international taxing authorities. In connection with the Separation, the Company entered into certain agreements with Danaher, including a tax matters agreement. The tax matters agreement distinguishes between the treatment of tax matters for “Joint” filings compared to “Separate” filings prior to the Separation. “Joint” filings involve legal entities, such as those in the United States, that include operations from both Danaher and the Company. By contrast, “Separate” filings involve certain entities (primarily outside of the United States) that exclusively include either Danaher’s or the Company’s operations, respectively. In accordance with the tax matters agreement, Danaher is liable for and has indemnified the Company against all income tax liabilities involving “Joint” filings for periods prior to the Separation. The Company remains liable for certain pre-Separation income tax liabilities including those related to the Company’s “Separate” filings.
The amount of income taxes the Company pays is subject to ongoing audits by federal, state and foreign tax authorities, which often result in proposed assessments. Management performs a comprehensive review of its global tax positions on a quarterly basis. Based on these reviews, the results of discussions and resolutions of matters with certain tax authorities, tax rulings and court decisions and the expiration of statutes of limitations, reserves for contingent tax liabilities are accrued or adjusted, as necessary. For a discussion of risks related to these and other tax matters, refer to “Item 1A. Risk Factors” in the 2025 Annual Report on Form 10-K.
COMPREHENSIVE INCOME
In 2026, comprehensive income decreased $114 million for the three-month period ended July 3, 2026 as compared to the comparable period in 2025, primarily driven by losses from foreign currency translation adjustments, partially offset by higher net earnings during the three-month period ended July 3, 2026. Comprehensive income decreased $178 million for the six-month period ended July 3, 2026 as compared to the comparable period in 2025, primarily driven by losses from foreign currency translation adjustments, partially offset by higher net earnings and unrealized gain on net investment hedges during the six-month period ended July 3, 2026. The Company recorded foreign currency translation losses of $12 million for the three-month period ended July 3, 2026, compared to foreign currency translation gains of $153 million, and an unrealized loss on net investment hedge of $32 million for the three-month period ended July 4, 2025. The foreign currency translation losses during the three-month period ended July 3, 2026 were driven by the strengthening of the U.S. dollar against most major foreign currencies in the period. The foreign currency translation gains during the three-month period ended July 4, 2025 were primarily driven by the weakening of the U.S. dollar against most major foreign currencies in the period. The Company recorded foreign currency translation losses of $59 million and an unrealized gain on net investment hedges of $12 million for the six-month period ended July 3, 2026, compared to foreign currency translation gains of $234 million, and an unrealized loss on net investment hedge of $54 million for the six-month period ended July 4, 2025. The foreign currency translation losses during the six-month period ended July 3, 2026 were driven by the strengthening of the U.S. dollar against most major foreign currencies in the period. The foreign currency translation gains during the six-month period ended July 4, 2025 were primarily driven by the weakening of the U.S. dollar against most major foreign currencies in the period. Foreign currency translation adjustments reflect the gain or loss resulting from the impact of the change in currency exchange rates on the Company’s foreign operations as they are translated to the Company’s reporting currency, the U.S. dollar.
LIQUIDITY AND CAPITAL RESOURCES
Management assesses the Company’s liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities. The Company continues to generate substantial cash from operating activities and believes that its operating cash flow and other sources of liquidity will be sufficient to allow it to continue to invest in existing businesses, consummate strategic acquisitions, make interest payments on its outstanding indebtedness, and manage its capital structure on a short and long-term basis.
During the second quarter of 2026, the Company completed an underwritten offering of $725 million aggregate principal amount of senior unsecured notes with a maturity date on January 15, 2032. The net proceeds from the issuance have been and will be used for general corporate purposes, which may include, without limitation, refinancing of outstanding indebtedness, working capital, capital expenditures and satisfaction of other obligations. Refer to Note 9 for additional information related to the Company’s long-term indebtedness.
36
Table of Contents
Shelf Registration Statement
On October 24, 2024, the Company filed a shelf registration statement on Form S-3 with the SEC (the “Shelf Registration Statement”) that registers an indeterminate amount of debt securities, common stock, preferred stock, depositary shares, subscription rights, purchase contracts, units and warrants that may be issued in the future in one or more offerings. Unless otherwise specified in the corresponding prospectus supplement, the Company expects to use net proceeds realized from future securities issuances off the Shelf Registration Statement for general corporate purposes, including without limitation repayment or refinancing of debt or other corporate obligations, acquisitions, capital expenditures, and working capital.
Overview of Cash Flows and Liquidity
Following is an overview of the Company’s cash flows and liquidity:
Six-Month Period Ended | |||||||||||
($ in millions) | July 3, 2026 | July 4, 2025 | |||||||||
Net cash provided by operating activities | $ | 522 | $ | 496 | |||||||
Cash paid for acquisitions, net of cash acquired | $ | (620) | $ | — | |||||||
Payments for additions to property, plant and equipment | $ | (24) | $ | (31) | |||||||
All other investing activities | (1) | (20) | |||||||||
Net cash used in investing activities | $ | (645) | $ | (51) | |||||||
Payment of dividends | $ | (64) | $ | (54) | |||||||
Proceeds from the issuance of common stock in connection with stock-based compensation | 5 | 13 | |||||||||
Net proceeds from borrowings (maturities longer than 90 days) | 719 | — | |||||||||
Payments for repurchase of common stock | (434) | — | |||||||||
Net cash provided by (used in) financing activities | $ | 226 | $ | (41) | |||||||
•Operating cash flows increased $26 million, or 5%, during the six-month period ended July 3, 2026 as compared to the comparable period in 2025, primarily driven by higher net income, partially offset by changes in net working capital.
•Net cash used in investing activities increased $594 million for the six-month period ended July 3, 2026 as compared to the comparable period in 2025, primarily driven by cash paid for the acquisitions of In-Situ and GlobalVision during the six-month period ended July 3, 2026.
•Net cash from financing activities increased $267 million for the six-month period ended July 3, 2026 as compared to the comparable period in 2025 primarily driven by net proceeds from the issuance of long-term debt offset by payments for share repurchases under the Company’s share repurchase program during the six-month period ended July 3, 2026.
Share Repurchase Program
For information regarding the Company’s share repurchase program, refer to Part II—Item 2, “Unregistered Sales of Equity Securities and Use of Proceeds”.
Dividends
Aggregate cash payments for dividends on Company common stock during the three-month period ended July 3, 2026 were $32 million.
In the second quarter of 2026, the Company declared a regular quarterly dividend of $0.13 per share of Company common stock payable on July 31, 2026 to holders of record as of June 30, 2026.
Cash and Cash Requirements
As of July 3, 2026, the Company held approximately $2.1 billion of cash and cash equivalents that were on deposit with financial institutions or invested in highly liquid investment-grade debt instruments with a maturity of 90 days or less. Of the cash and cash equivalents, approximately $1,004 million was held within the United States and
37
Table of Contents
approximately $1,115 million was held outside of the United States. The Company will continue to have cash requirements to support general corporate purposes, which may include working capital needs, capital expenditures, acquisitions and investments, paying interest and servicing debt, paying taxes and any related interest or penalties, funding its restructuring activities and pension plans as required, paying dividends to shareholders, repurchasing shares of the Company’s common stock and supporting other business needs.
The Company generally intends to use available cash and internally generated funds to meet these cash requirements, but in the event that additional liquidity is required, the Company may also borrow under its commercial paper programs (if available) or borrow under the Company’s credit facility, enter into new credit facilities and either borrow directly thereunder or use such credit facilities to backstop additional borrowing capacity under its commercial paper programs (if available) and/or access the capital markets. The Company also may from time to time seek to access the capital markets to take advantage of favorable interest rate environments or other market conditions.
Repatriation of some cash held outside the United States may be restricted by local laws. In general, repatriation of cash to the United States can be completed with no material incremental U.S. tax; however, repatriation of cash could subject the Company to non-U.S. withholding taxes and U.S. state income taxes on such distributions. The cash that the Company’s non-U.S. subsidiaries hold for indefinite reinvestment is generally used to finance foreign operations and investments, including acquisitions. However, the Company could make a distribution to the extent it has been previously taxed on such earnings in the United States. The potential tax implications of repatriating previously taxed earnings are driven by the facts at the time of distribution with the incremental cost to repatriate these earnings not expected to be material. As of July 3, 2026, management believes that it has sufficient sources of liquidity to satisfy its cash needs, including its cash needs in the United States.
Contractual Obligations
For a description of the Company’s debt and lease obligations, commitments, and litigation and contingencies, refer to Notes 8, 12, 15 and 16 to the audited Consolidated Financial Statements included within the 2025 Annual Report on Form 10-K.
CRITICAL ACCOUNTING ESTIMATES
There have been no material changes to the Company’s critical accounting estimates as described in the 2025 Annual Report on Form 10-K.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Quantitative and qualitative disclosures about market risk appear in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Financial Instruments and Risk Management,” within the 2025 Annual Report on Form 10-K. There were no material changes during the three-month period ended July 3, 2026 to this information as reported in the 2025 Annual Report on Form 10-K.
ITEM 4. CONTROLS AND PROCEDURES
The Company’s management, with the participation of the Company’s President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on such evaluation, the Company’s President and Chief Executive Officer, and Senior Vice President and Chief Financial Officer, have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective.
There have been no changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the Company’s most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
38
Table of Contents
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
For additional information regarding legal proceedings, refer to the section titled “Legal Proceedings” in the MD&A section of the Company’s 2025 Annual Report on Form 10-K.
ITEM 1A. RISK FACTORS
There were no material changes during the quarter ended July 3, 2026 to the risk factors previously disclosed in the “Item 1A. Risk Factors” section of the 2025 Annual Report on Form 10-K, and as updated in the Company’s Form 10-Q for the period ended April 3, 2026.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
On November 25, 2025, the Company announced that its Board of Directors approved a share repurchase program (the “Repurchase Program”) authorizing the repurchase of up to $750 million of the Company’s common stock from time to time on the open market (including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), in privately negotiated transactions or by other methods, at the Company’s discretion. The program does not obligate the Company to acquire any particular amount of its common stock, has no expiration date, and will continue until otherwise suspended or terminated at any time for any reason. The timing and amount of any shares repurchased under the Repurchase Program will be determined by members of the Company’s management based on its evaluation of market, business conditions, and other factors.
The following table provides details about our share repurchases, including those pursuant to a Rule 10b5-1 plan, during the fiscal quarter ended July 3, 2026:
Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Program | Maximum Approximate Dollar Value of Shares That May Yet Be Purchased Under the Program ($ in millions) | |||||||||||||||||||
April 4, 2026 - May 1, 2026 | — | $ | — | — | $ | 450 | |||||||||||||||||
May 2, 2026 - May 29, 2026 | 949,600 | 86.87 | 949,600 | 368 | |||||||||||||||||||
May 30, 2026 - July 3, 2026 | 600,281 | 84.97 | 600,281 | 317 | |||||||||||||||||||
Total (1) | 1,549,881 | $ | 86.13 | 1,549,881 | $ | 317 | |||||||||||||||||
(1) Amounts exclude excise taxes and other transaction costs
ITEM 5. OTHER INFORMATION
Director and Officer Trading Arrangements
On May 18, 2026 , Surekha Trivedi , Veralto’s Senior Vice President, Strategy and Sustainability , adopted a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1 under the Exchange Act to sell up to 39,398 shares of common stock, subject to certain conditions. Unless otherwise terminated pursuant to its terms, the plan will terminate on March 1, 2027 , or when all of the shares under the plan are sold.
No other directors or executive officers of the Company adopted , modified or terminated
39
Table of Contents
ITEM 6. EXHIBITS
(a)Exhibits:
3.1 | Corrected Second Amended and Restated Certificate of Incorporation of Veralto Corporation (incorporated by reference to Exhibit 3.1 to Veralto Corporation’s Quarterly Report on Form 10-Q filed April 29, 2026) | ||||
3.2 | Second Amended and Restated Bylaws of Veralto Corporation (incorporated by reference to Exhibit 3.2 to Veralto Corporation’s Current Report on Form 8-K filed May 15, 2025) | ||||
4.1 | Indenture, dated as of June 1, 2026, between the Company, as issuer, and Deutsche Bank Trust Company Americas, as trustee (incorporated by reference to Exhibit 4.1 to Veralto Corporation’s Current Report on Form 8-K filed June 1, 2026) | ||||
4.2 | First Supplemental Indenture, dated as of June 1, 2026, between the Company, as issuer, and Deutsche Bank Trust Company Americas, as trustee (incorporated by reference to Exhibit 4.2 to Veralto Corporation’s Current Report on Form 8-K filed June 1, 2026) | ||||
10.1 | Addendum to Offer Letter, dated April 24, 2026, between Melissa Kapity and VL Employment LLC (incorporated by reference to Exhibit 10.1 to Veralto Corporation’s Quarterly Report on Form 10-Q filed April 29, 2026) | ||||
31.1 | Certification of Chief Executive Officer Pursuant to Item 601(b)(31) of Regulation S-K, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||||
31.2 | Certification of Chief Financial Officer Pursuant to Item 601(b)(31) of Regulation S-K, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | ||||
32.1 | Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||||
32.2 | Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | ||||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | ||||
101.SCH | Inline XBRL Taxonomy Extension Schema Document | ||||
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | ||||
40
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
VERALTO CORPORATION | |||||||||||
Date: | July 28, 2026 | By: | /s/ Sameer Ralhan | ||||||||
Sameer Ralhan | |||||||||||
Senior Vice President and Chief Financial Officer | |||||||||||
Date: | July 28, 2026 | By: | /s/ Bernard M. Skeete | ||||||||
Bernard M. Skeete | |||||||||||
Vice President and Chief Accounting Officer | |||||||||||
41